FR2126760A5 - - Google Patents

Info

Publication number
FR2126760A5
FR2126760A5 FR7204056A FR7204056A FR2126760A5 FR 2126760 A5 FR2126760 A5 FR 2126760A5 FR 7204056 A FR7204056 A FR 7204056A FR 7204056 A FR7204056 A FR 7204056A FR 2126760 A5 FR2126760 A5 FR 2126760A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7204056A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of FR2126760A5 publication Critical patent/FR2126760A5/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
FR7204056A 1971-02-10 1972-02-08 Expired FR2126760A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL717101728A NL154600B (nl) 1971-02-10 1971-02-10 Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.

Publications (1)

Publication Number Publication Date
FR2126760A5 true FR2126760A5 (fr) 1972-10-06

Family

ID=19812444

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7204056A Expired FR2126760A5 (fr) 1971-02-10 1972-02-08

Country Status (16)

Country Link
US (1) US3791932A (fr)
JP (1) JPS5247011B1 (fr)
AU (1) AU468151B2 (fr)
BE (1) BE779209A (fr)
BR (1) BR7200729D0 (fr)
CA (2) CA958314A (fr)
CH (1) CH573115A5 (fr)
DE (1) DE2206103B2 (fr)
DK (1) DK150170C (fr)
ES (1) ES399608A1 (fr)
FI (1) FI53894C (fr)
FR (1) FR2126760A5 (fr)
GB (1) GB1363565A (fr)
NL (1) NL154600B (fr)
SE (1) SE451098B (fr)
ZA (1) ZA72548B (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2298798A1 (fr) * 1975-01-27 1976-08-20 Kabk Ab Dispositif et procede pour dosages quantitatifs immuno-chimiques
FR2325934A1 (fr) * 1975-09-29 1977-04-22 Cordis Corp Methode de detection de la presence d'un antigene associe a l'hepatite
FR2373795A1 (fr) * 1976-12-10 1978-07-07 Erba Carlo Spa Dosage immunologique par enzyme fixee
FR2426262A1 (fr) * 1978-05-19 1979-12-14 Becton Dickinson Co Procede d'essai de substances biologiques en phase solide
FR2433749A1 (fr) * 1978-07-28 1980-03-14 Abbott Lab Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
EP0038150A1 (fr) * 1980-04-10 1981-10-21 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Procédé de sérodiagnostic pour la syphilis et autres maladies
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
FR2511155A1 (fr) * 1981-08-10 1983-02-11 Corning Glass Works Detection d'anticorps auto-bloquant

Families Citing this family (957)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203802A (en) * 1971-05-14 1980-05-20 Syva Company Inhibitable enzyme amplification assay
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US3904367A (en) * 1973-08-15 1975-09-09 Gen Electric Contrast enhancement for immunological film detection
US4039652A (en) * 1973-10-11 1977-08-02 Miles Laboratories, Inc. Column method of immunoassay employing an immobilized binding partner
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease
NL7501215A (nl) * 1975-02-01 1976-08-03 Akzo Nv Methode voor het aantonen en bepalen van een antigeen of antilichaam.
IN142734B (fr) * 1975-04-28 1977-08-20 Miles Lab
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4642285A (en) * 1975-09-29 1987-02-10 Diamedix Corporation Sandwich EIA for antigen
US4474878A (en) * 1975-09-29 1984-10-02 Cordis Laboratories, Inc. Sandwich EIA for antigen associated with hepatitis
US4116776A (en) * 1976-04-19 1978-09-26 International Radioimmune Systems, Inc. Diagnostic blood test and kit for detecting human chorionic gonadotropin
GB1572220A (en) * 1976-10-07 1980-07-30 Mochida Pharm Co Ltd Immunochemical process of measuring physiologically active substances
JPS5399319A (en) * 1977-02-09 1978-08-30 Hidematsu Hirai Novel qualitative and quantitative detecting method and detecting body for antgenic substance
IT1153999B (it) * 1977-03-15 1987-01-21 Snam Progetti Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
IL51668A (en) * 1977-03-16 1981-12-31 Israel State Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
CA1108516A (fr) * 1977-11-21 1981-09-08 Stanley E. Charm Methode pour detecter les traces d'antibiotiques
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
NL7804144A (nl) * 1978-04-18 1979-10-22 Akzo Nv Inrichting voor clorimetrische bepalingen.
JPS54170918U (fr) * 1978-05-23 1979-12-03
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
US4240751A (en) * 1978-11-09 1980-12-23 Akzona Incorporated Method and apparatus for specific binding substances
US4318707A (en) * 1978-11-24 1982-03-09 Syva Company Macromolecular fluorescent quencher particle in specific receptor assays
US4374925A (en) * 1978-11-24 1983-02-22 Syva Company Macromolecular environment control in specific receptor assays
JPS55116258A (en) * 1979-03-01 1980-09-06 Fuji Photo Film Co Ltd Microimmunoassay method
JPS55116259A (en) * 1979-03-01 1980-09-06 Fuji Photo Film Co Ltd Microimmunoassay method
US4269938A (en) * 1979-03-08 1981-05-26 Eastman Kodak Company Assay of peroxidatively active materials
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
GB2059421A (en) * 1979-10-03 1981-04-23 Self C H Assay method and reagents therefor
US4446231A (en) * 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
US4347312A (en) * 1980-03-20 1982-08-31 Research Triangle Institute Detection of antibiotics in milk
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
DE3016575A1 (de) * 1980-04-30 1981-11-05 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
US6406920B1 (en) 1980-06-20 2002-06-18 Inverness Medical Switzerland Gmbh Processes and apparatus for carrying out specific binding assays
EP0146654A3 (fr) * 1980-06-20 1986-08-20 Unilever Plc Procédé et dispositif pour la réalisation d'essais à liaison spécifique
NL185309C (nl) 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4323647A (en) * 1980-10-15 1982-04-06 University Of Miami Steric hindrance enzyme immunoassay
NZ199286A (en) * 1980-12-22 1986-05-09 Commw Serum Lab Commission A method of detecting antibodies or an antigenic or haptenic substance in a sample
US4517288A (en) * 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4425438A (en) * 1981-03-13 1984-01-10 Bauman David S Assay method and device
GB2095258B (en) * 1981-03-19 1984-09-05 Janssen Pharmaceutica Nv A bright field light microscopic method of localizing tissue antigens
US4592995A (en) * 1981-03-30 1986-06-03 Dainippon Pharmaceutical Co., Ltd. Reagent for streptococcal anti-esterase assay
US4604365A (en) * 1981-06-02 1986-08-05 Electro-Nucleonics, Inc. Immunoprecipitation assay
JPS57193643U (fr) * 1981-06-03 1982-12-08
WO1983000877A1 (fr) * 1981-08-31 1983-03-17 Icl Scient Detection immunohistochimique a l'oxydase de glucose d'anticorps anti-nucleaires
US4452886A (en) * 1981-09-21 1984-06-05 Henry Robert P Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
US4446232A (en) * 1981-10-13 1984-05-01 Liotta Lance A Enzyme immunoassay with two-zoned device having bound antigens
US4753875A (en) * 1981-11-02 1988-06-28 Ryan James W Method for assaying proteases with tagged proteinaceous inhibitors
US4506009A (en) * 1982-03-30 1985-03-19 University Of California Heterogeneous immunoassay method
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
US4503143A (en) * 1982-08-20 1985-03-05 Btc Diagnostics Limited Partnership Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
US4530900A (en) * 1982-09-13 1985-07-23 Seragen Diagnostics Inc. Soluble insoluble polymers in enzymeimmunoassay
FR2550799B1 (fr) * 1983-08-17 1986-02-21 Commissariat Energie Atomique Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
WO1985002260A1 (fr) * 1983-11-08 1985-05-23 Quidel Appareil et procede d'analyse immunologique a plongeur rapide
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4645828A (en) 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4665020A (en) * 1984-05-30 1987-05-12 United States Department Of Energy Flow cytometer measurement of binding assays
US4812395A (en) * 1984-11-05 1989-03-14 E. I. Du Pont De Nemours And Company Method for detecting enzymatic activity using particle agglutination
US4812396A (en) * 1984-11-05 1989-03-14 E. I. Du Pont De Nemours And Company Method for detecting enzymatic activity using particle agglutination
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4824784A (en) * 1985-04-08 1989-04-25 Hygeia Sciences, Incorporated Chromogenic solution for immunoassay
US4837395A (en) * 1985-05-10 1989-06-06 Syntex (U.S.A.) Inc. Single step heterogeneous assay
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
US4868108A (en) * 1985-12-12 1989-09-19 Hygeia Sciences, Incorporated Multiple-antibody detection of antigen
CH670709A5 (fr) * 1986-04-24 1989-06-30 Univ Moskovsk
US5039607A (en) * 1988-05-17 1991-08-13 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5334513A (en) * 1988-05-17 1994-08-02 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
US5135863A (en) * 1988-12-23 1992-08-04 Syntex (U.S.A.) Inc. Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
WO1992020820A1 (fr) * 1991-05-15 1992-11-26 Vanderbilt University Methode de determination du potentiel metastatique des cellules tumorales
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5874423A (en) * 1992-09-10 1999-02-23 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Digitalis-like compounds
US6953573B1 (en) * 1993-03-17 2005-10-11 University Of Washington Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
AU679008B2 (en) * 1993-05-06 1997-06-19 Chiron Diagnostics Corporation Mixed luminescent conjugate test assays
WO1995034640A1 (fr) * 1994-06-13 1995-12-21 Henry Ford Health System Neuronatine, nouveau gene neuronal neonatal
US5698686A (en) 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US6531277B2 (en) 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
US5858661A (en) 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US5728807A (en) * 1995-05-16 1998-03-17 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Mutated proteins associated with ataxia-telangiectasia
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US6689757B1 (en) 1996-02-12 2004-02-10 M.L. Laboratories Plc Methods for vaccination and vaccines therefor
US6942862B2 (en) * 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
US20050069923A1 (en) * 1996-07-08 2005-03-31 Mullis Kary Banks Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
EP0918845A4 (fr) 1996-07-08 2000-08-30 Burstein Lab Inc Procede et dispositif a element de signal clivable
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
US6331275B1 (en) 1996-07-08 2001-12-18 Burstein Technologies, Inc. Spatially addressable, cleavable reflective signal elements, assay device and method
US6342349B1 (en) 1996-07-08 2002-01-29 Burstein Technologies, Inc. Optical disk-based assay devices and methods
US5840322A (en) * 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
EP1015471A1 (fr) * 1997-08-21 2000-07-05 Quark Biotech, Inc. Genes regules au niveau de l'hypoxemie
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
EP1027453A4 (fr) 1997-10-17 2004-12-01 Univ South Florida Procede de diagnostic et de surveillance des deficiences immunitaires cellulaires
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US20080206206A1 (en) 1998-05-07 2008-08-28 University Of South Florida Bone marrow-derived neuronal cells
US6344443B1 (en) 1998-07-08 2002-02-05 University Of South Florida Peptide antagonists of tumor necrosis factor alpha
AU4994899A (en) 1998-07-13 2000-02-01 University Of South Florida Modulation of the phospholipase a2 pathway as a therapeutic
CA2338401A1 (fr) * 1998-07-21 2000-02-03 Burstein Laboratories, Inc Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
DE69836493T2 (de) 1998-07-22 2007-09-06 Syntron Bioresearch, Inc., Carlsbad Vorrichtung zur bestimmung von mehreren analyten
US6187563B1 (en) 1998-08-07 2001-02-13 Yale University βIV-spectrin-polypeptides and nucleic acids encoding same
BR9914465A (pt) * 1998-09-29 2001-10-09 Gamida Cell Ltd Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
EP1131633A2 (fr) 1998-11-16 2001-09-12 Board of Regents, The University of Texas System Induction de lymphocytes t specifiques du vih
EP2311938B1 (fr) * 1999-02-04 2016-04-06 Pluristem Ltd. Méthode et appareil de renouvellement et de multiplication de cellules souches hematopoietiques et/ou de progéniteurs
US6440682B1 (en) * 1999-05-28 2002-08-27 Detroit R&D Inc. Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en) * 1999-06-01 2004-09-07 Roskamp Research Institute, Llc Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
WO2001000859A1 (fr) * 1999-06-25 2001-01-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Procede permettant d'induire une angiogenese au moyen de micro-organes
US6875582B1 (en) 1999-08-19 2005-04-05 Omniscience Pharmaceuticals, Inc. Methods and targets of antibiotic resistance
US7811981B2 (en) * 1999-08-30 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
US7101839B1 (en) 1999-08-30 2006-09-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
US7167615B1 (en) 1999-11-05 2007-01-23 Board Of Regents, The University Of Texas System Resonant waveguide-grating filters and sensors and methods for making and using same
EP1230343B1 (fr) 1999-11-19 2006-08-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Gene et proteine de beta-glucosidase d'aspergillus niger et leurs utilisations
US6544506B2 (en) * 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
WO2001053323A2 (fr) * 2000-01-24 2001-07-26 Ramot University Authority For Applied Research & Industrial Development Ltd. Plantes tolerant le stress de l'environnement, procedes d'elaboration pour ce type de plante et sequence polynucleotidique utilisee a cet effet
US20040191260A1 (en) * 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
JP2004503213A (ja) 2000-03-27 2004-02-05 テクニオン　リサーチ　アンド　ディベロップメント　ファウンデーション　リミテッド １本鎖クラスｉ主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
HUP0300810A2 (hu) 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
PT2359854E (pt) 2000-08-08 2013-11-22 Technion Res & Dev Foundation Composições farmacêuticas e métodos úteis para a modulação da angiogénese
EP1683874A3 (fr) 2000-08-29 2006-10-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
US20070281037A9 (en) * 2000-09-28 2007-12-06 Nanocyte Inc. Sterile preparations and compositions including stinging capsules and methods of producing and using same
IL155097A0 (en) * 2000-09-28 2003-10-31 Nanocyte Inc Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US7632522B2 (en) * 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
EP1343894A4 (fr) * 2000-11-02 2005-05-04 Univ Singapore Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
CA2429342C (fr) 2000-11-17 2013-03-19 Vascular Biogenics Ltd. Promoteurs presentant une specificite pour des cellules endotheliales et leurs procedes d'utilisation
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
KR100865142B1 (ko) 2000-11-24 2008-10-24 바스큘라 바이오제닉스 리미티드 죽상 경화증의 예방 및 치료를 위해 정의된 산화 인지질을사용하는 방법 및 이를 함유하는 조성물
US20020172980A1 (en) * 2000-11-27 2002-11-21 Phan Brigitte Chau Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
US20040248093A1 (en) * 2000-11-27 2004-12-09 Coombs James Howard Magneto-optical bio-discs and systems including related methods
US20030003464A1 (en) * 2000-11-27 2003-01-02 Phan Brigitte C. Dual bead assays including optical biodiscs and methods relating thereto
KR20030067696A (ko) 2000-11-30 2003-08-14 모렉큐랄 스킨케어 리미티드 질병의 진단 및 치료
EP1337152A4 (fr) * 2000-11-30 2004-08-11 Yeda Res & Dev Methodes d'utilisation de lymphocytes t mis en culture et n'induisant pas de reaction du greffon contre l'hote (gvhd) pour traiter des maladies
US20020142287A1 (en) * 2000-12-14 2002-10-03 Hirotaka Yamamoto High throughput assay to detect inhibitors of the map kinase pathway
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
US20050202098A1 (en) * 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
AU2002230061A1 (en) * 2001-01-31 2002-08-12 Tolaren Induction of tolerance by apoptotic and/or necrotic cells
US20030003454A1 (en) 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
EP1493014A2 (fr) 2001-04-11 2005-01-05 Burstein Technologies, Inc. Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
WO2003008534A2 (fr) * 2001-07-19 2003-01-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Polypeptides possedant une activite catalytique d'isomerase de carotenoides, acides nucleiques codant pour ces polypeptides et applications de ceux-ci
CA2458640A1 (fr) 2001-08-16 2003-03-06 Bar-Ilan University Diagnostic, prevention et traitement du cancer
US7138144B2 (en) * 2001-09-07 2006-11-21 Nadir Askenasy Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
US20040136972A1 (en) 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
JP4173446B2 (ja) 2001-10-19 2008-10-29 ヴァスキュラー バイオジェニックス リミテッド 血管形成の標的化されたダウンレギュレーションおよび抗ガン治療のためのポリヌクレオチド構築物および薬学的組成物および方法
AUPR842501A0 (en) * 2001-10-23 2001-11-15 Epipop Pty Ltd A method for identification and development of therapeutic agents
US6867005B2 (en) 2001-10-24 2005-03-15 Beckman Coulter, Inc. Method and apparatus for increasing the dynamic range and accuracy of binding assays
US6696254B2 (en) 2001-11-21 2004-02-24 Kimberly-Clark Worldwide, Inc. Detection and identification of enteric bacteria
WO2003048298A2 (fr) * 2001-12-05 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
US20050085432A1 (en) * 2001-12-26 2005-04-21 Aviva Lapidot Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (fr) * 2002-01-25 2006-06-07 Gamida Cell Ltd Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
WO2005000193A2 (fr) * 2003-06-30 2005-01-06 Tel Aviv University Future Technology Development L.P. Peptides, anticorps diriges contre les maladies associees a l'amyloide et procedes d'utilisation pour le diagnostic et le traitement de ces maladies
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US6992176B2 (en) * 2002-02-13 2006-01-31 Technion Research & Development Foundation Ltd. Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
CA2476625A1 (fr) * 2002-02-20 2003-08-28 Dyax Corp. Ligands de liaison au complexe mhc-peptide
SI3031910T1 (en) 2002-02-21 2018-05-31 Institute Of Virology Slovak Academy Of Sciences MN / CA IX-SPECIFIC MONOCLONIC PROTECTOR GENERATED FROM MN / CA- DEFROSTABLE MICE AND METHOD OF APPLICATION
JP2005520511A (ja) * 2002-03-18 2005-07-14 ガミダ セル リミテッド エクスビボ拡大培養された幹細胞における分化を誘導する方法
AU2003215878A1 (en) * 2002-03-26 2003-10-08 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
WO2003089659A1 (fr) * 2002-04-16 2003-10-30 The Regents Of The University Of California Methodes de pronostic d'un hypernephrome et selection de traitement a l'aide d'une anhydrase ix carbonique
US20040121442A1 (en) * 2002-05-05 2004-06-24 Ilan Chet Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
JP2005533102A (ja) * 2002-07-12 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 微小器官によって生物学的プロセスを誘発する方法と装置
CA2494348C (fr) 2002-08-01 2014-04-08 Yeda Research And Development Co. Ltd. Methode et composition pour la protection du tissu neuronal contre une lesion induite par des taux de glutamate eleves
WO2004018698A2 (fr) 2002-08-20 2004-03-04 Genitrix, Llc Compositions de lectine et technique de modulation dune reponse a un antigene
US7267981B2 (en) 2002-10-07 2007-09-11 Technion Research & Development Foundation Ltd. Human foreskin fibroblasts for culturing ES cells
US20040146949A1 (en) * 2002-10-25 2004-07-29 Jun Tan Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
EP1578999B1 (fr) 2002-10-30 2013-01-16 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Procede pour la mesure de fer non lie par la transferrine
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
AU2003302701A1 (en) * 2002-11-29 2004-06-23 Technion Research And Development Foundation Ltd. Method of dynamically culturing embryonic stem cells
US7491699B2 (en) * 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583512B3 (fr) 2002-12-12 2012-12-05 R.B.T. (Rakuto Bio Technologies) Ltd. Utilisation de lignine peroxydase pour eclaircir la peau et les cheveux
CN100549163C (zh) 2002-12-16 2009-10-14 技术研究及发展基金有限公司 制备无饲养细胞、无异源的人胚胎干细胞的方法以及使用该方法制备的干细胞培养物
EP1572714A4 (fr) 2002-12-20 2006-08-09 Univ Texas Sequences d'especes et de souches de i borrelia /i pathogene de type vmp
AU2003288700B2 (en) 2003-01-02 2009-11-19 Rappaport Family Institute For Research In The Medical Sciences Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
ATE426575T1 (de) * 2003-01-07 2009-04-15 Univ Ramot Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
JP2007501407A (ja) * 2003-03-03 2007-01-25 長岡実業株式会社 多様な細胞タイプの検出および定量に使用される方法および装置並びにこれを行うための光バイオディスクの使用
EP1599598A4 (fr) 2003-03-04 2007-08-08 Yeda Res & Dev Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
WO2004078917A2 (fr) * 2003-03-07 2004-09-16 Gamida-Cell Ltd. Extension de populations de cellules souches renouvelables au moyen de modulateurs de kinase pi 3
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
ES2369498T3 (es) 2003-04-04 2011-12-01 Yeda Research And Development Co., Ltd. Anticuerpos para inhibir la actividad de mmp-2 y mmp-9.
JP4865540B2 (ja) 2003-04-08 2012-02-01 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド 化学誘引物質に対する増大された感受性を有する幹細胞およびそれを産生および使用する方法
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
WO2005035556A2 (fr) * 2003-05-06 2005-04-21 Iguazu Biosciences Corp. Particules pseudo-virales du coronavirus du sras et methodes d'utilisation
BRPI0411182B1 (pt) 2003-05-22 2019-08-20 Evogene Ltd. Método para aumentar a tolerância de uma planta ao estresse salino e construto deácido nucleico
AU2005234725B2 (en) * 2003-05-22 2012-02-23 Evogene Ltd. Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
US7554007B2 (en) * 2003-05-22 2009-06-30 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants
EP1635765B1 (fr) 2003-05-23 2013-07-17 Board Of Regents, The University Of Texas System Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
US20050020499A1 (en) * 2003-05-27 2005-01-27 Bar Ilan University Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
EP1636333A4 (fr) * 2003-06-19 2007-10-24 Evogene Ltd Sequences nucleotidiques pour reguler l'expression genetique chez des trichromes vegetaux, et genes hybrides et procedes dans lesquels elles interviennent
US8129514B2 (en) * 2003-06-19 2012-03-06 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US20070041971A1 (en) * 2003-07-07 2007-02-22 Wagner David H Methods for predicting development of auto-immune diseases and treatment of same
AU2004267383A1 (en) * 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
US7625707B2 (en) 2003-10-02 2009-12-01 Ramot At Tel Aviv University Ltd. Antibacterial agents and methods of identifying and utilizing same
PL1678209T3 (pl) 2003-10-07 2011-09-30 Yeda Res & Dev Przeciwciała skierowane przeciwko NIK, ich wytwarzanie i zastosowanie
IL158287A0 (en) 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
MXPA06004537A (es) * 2003-10-23 2006-06-23 Pfizer Prod Inc Vacuna para la enfermedad periodontal.
EP1682178B8 (fr) 2003-11-04 2010-09-01 Novartis Vaccines and Diagnostics, Inc. Procedes de therapie pour des cancers exprimant l'antigene cd40
PT1680141E (pt) 2003-11-04 2010-12-20 Novartis Vaccines & Diagnostic Métodos terapêuticos para tumores sólidos que expressam o antigénio de superfície celular cd40
EP2243492A1 (fr) 2003-11-04 2010-10-27 Novartis Vaccines and Diagnostics, Inc. Utilisation d'anticorps monoclonaux antagonistes anti-CD40 pour le traitement de myélome multiple
PT1682177E (pt) 2003-11-04 2010-11-29 Xoma Technology Lt Utilização de anticorpos antagonistas anti-cd40 para o tratamento da leucemia linfocítica crónica
WO2005051423A2 (fr) 2003-11-30 2005-06-09 Yeda Research And Development Co. Ltd Procedes et agents pour mettre en oeuvre une modulation immunitaire et procedes d'identification de modulateurs immunitaires
WO2005059100A2 (fr) * 2003-12-12 2005-06-30 New York University Procedes et compositions se rapportant a la cystatine c
US20100221233A1 (en) * 2003-12-15 2010-09-02 University Of South Florida Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
EP1722834B1 (fr) 2003-12-22 2012-06-27 Regentis Biomaterials Ltd. Matrice comprenant un squelette proteique reticule naturel
US8007847B2 (en) * 2004-01-13 2011-08-30 Eytan Biderman Feeding formula appliance
US7423139B2 (en) * 2004-01-20 2008-09-09 Insight Biopharmaceuticals Ltd. High level expression of recombinant human erythropoietin having a modified 5′-UTR
EP1713900A4 (fr) * 2004-01-27 2009-06-17 Compugen Ltd Procedes et systemes pour l'annotation de sequences de biomolecules
EP3006039B1 (fr) 2004-03-02 2021-01-06 Acceleron Pharma Inc. Alk7 polypeptides pour stimuler la perte de graisse
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
CA2570195C (fr) 2004-06-14 2017-10-24 Evogene Ltd. Polynucleotides et polypeptides impliques dans le developpement de la fibre vegetale et procedes permettant de les utiliser
US8680062B2 (en) * 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en) * 2004-07-15 2009-06-18 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
CA2579676A1 (fr) 2004-09-08 2007-02-15 Hana Golding Compositions et methodes pour detecter une infection par le vih-1/vih-2
WO2006030442A2 (fr) * 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methodes de culture ex vivo de cellules souches et de precurseur par co-culture avec des cellules mesenchymales
US8000900B2 (en) 2004-09-21 2011-08-16 Microsoft Corporation Association-based predictions of pathogen characteristics
US20060095241A1 (en) * 2004-10-29 2006-05-04 Microsoft Corporation Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
WO2006035442A2 (fr) 2004-09-29 2006-04-06 Collplant Ltd. Collagene de recombinaison produit dans une plante
CA2582041C (fr) * 2004-09-29 2015-08-04 Levava Roiz Rnase t2 humaine recombinee et utilisations associees
WO2006040765A1 (fr) * 2004-10-12 2006-04-20 Closed Loop Therapies Ltd. Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
US8478535B2 (en) 2004-10-29 2013-07-02 Microsoft Corporation Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
US20090118132A1 (en) * 2004-11-04 2009-05-07 Roche Molecular Systems, Inc. Classification of Acute Myeloid Leukemia
US7842794B2 (en) 2004-12-17 2010-11-30 Roche Molecular Systems, Inc. Reagents and methods for detecting Neisseria gonorrhoeae
US20060134680A1 (en) * 2004-12-22 2006-06-22 Alexander Kotlyar Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
JP2008529325A (ja) * 2005-01-16 2008-07-31 ズランゴー リミテッド 通信ネットワークシステムおよびそれを使用するための方法
US8375327B2 (en) * 2005-01-16 2013-02-12 Zlango Ltd. Iconic communication
WO2007080558A2 (fr) * 2006-01-16 2007-07-19 Zlango Ltd. Systeme de reseau de communication et ses procedes d'utilisation
WO2006080021A2 (fr) 2005-01-31 2006-08-03 Realbio Technologies Ltd. Dispositif capillaire a flux lateral de reaction par etapes multiples
US8257742B2 (en) 2005-02-17 2012-09-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates for treating endometriosis
US8216801B2 (en) 2005-02-25 2012-07-10 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center Methods for treating inflammatory disorders
US7695927B2 (en) * 2005-03-18 2010-04-13 Detroit R & D Detection of hypertension using glucuronidated metabolic products
WO2006109312A2 (fr) * 2005-04-15 2006-10-19 Vascular Biogenics Ltd. Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
WO2006125117A2 (fr) 2005-05-18 2006-11-23 Novartis Ag Procedes de diagnostic et de traitement de maladies ayant une composante auto-immune et/ou inflammatoire
EP2279726A3 (fr) 2005-05-26 2012-06-20 Biorest Ltd. Compositions et méthodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protégé par une barrière sanguine
DK1893747T3 (en) 2005-06-16 2014-12-01 Univ Ramot ISOLATED CELLS AND POPULATIONS INCLUDING SUCH CELLS FOR TREATING CNS DISEASES
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
US20060292559A1 (en) * 2005-06-23 2006-12-28 Beckman Coulter, Inc. Cell-based microarrays, and methods for their preparation and use
CA2614531C (fr) * 2005-07-07 2015-06-16 Avraham Hochberg Agents de type acide nucleique pour la regulation a la baisse de h19 et methodes d'emploi desdits agents
US9051379B2 (en) 2005-07-07 2015-06-09 Fulcrum Sp Ltd. Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
US20110070201A1 (en) 2005-07-18 2011-03-24 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
CA2616766A1 (fr) 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Profils d'anticorps specifiques d'un etat tuberculeux
JP2009504659A (ja) * 2005-08-08 2009-02-05 オンコノン・リミテッド・ライアビリティ・カンパニー 抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
EP1928479B1 (fr) 2005-08-24 2016-06-08 Yeda Research And Development Co., Ltd. Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
AU2006286149B2 (en) 2005-08-29 2012-09-13 Technion Research And Development Foundation Ltd. Media for culturing stem cells
JP2009508516A (ja) 2005-09-22 2009-03-05 イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 核酸構築物、薬剤組成物、及び癌治療のためのその使用方法
US20070087437A1 (en) * 2005-10-14 2007-04-19 Jifan Hu Methods for rejuvenating cells in vitro and in vivo
AU2006307457B2 (en) 2005-10-24 2012-03-22 Evogene Ltd. Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
WO2007063545A2 (fr) 2005-11-29 2007-06-07 Gamida-Cell Ltd. Methodes d'amelioration de prise de greffe et de nostocytose de cellules souches
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
EP1977312A2 (fr) 2006-01-16 2008-10-08 Zlango Ltd. Communication iconique
EP2368570A3 (fr) 2006-01-18 2012-05-02 University Of Chicago Compositions et procédés liés aux protéines des bactéries staphylocoques
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US8759292B2 (en) 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US7553940B2 (en) 2006-02-03 2009-06-30 Modigene Inc Long-acting EPO polypeptides and derivatives thereof and methods thereof
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
CA2641079A1 (fr) 2006-02-06 2007-08-16 Rappaport Family Institute For Research In The Medical Sciences Methodes et trousse pour le diagnostic du diabete de type 1
JP5107943B2 (ja) 2006-03-06 2012-12-26 ゼティク テクノロジーズ リミテッド 細胞の表現型を特定するための方法および組成物
DK2626417T3 (en) 2006-03-23 2015-11-02 Pluristem Ltd Methods for cell expansion and use of the thus produced cells and conditioned media for the therapy
US20090226909A1 (en) 2006-03-28 2009-09-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for Determining Predisposition to Warfarin Resistance
KR20090029184A (ko) * 2006-04-07 2009-03-20 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 항체 조성물 및 신생물성 질병의 치료 방법
NZ571757A (en) 2006-04-21 2012-01-12 Novartis Ag Antagonist anti-CD40 antibody pharmaceutical compositions comprising arginine-HCl and a citrate or citric acid buffer
ES2549128T3 (es) * 2006-05-19 2015-10-23 Technion Research And Development Foundation Ltd. Proteínas de fusión, usos de las mismas y procesos para producir las mismas
US20070281883A1 (en) * 2006-06-05 2007-12-06 Hanna Rosenfeld Development of follicle stimulating hormone agonists and antagonists in fish
US8629259B2 (en) 2006-07-20 2014-01-14 Yeda Research And Development Co. Ltd. Photosynthetic organisms and compositions and methods of generating same
US8809052B2 (en) 2006-08-28 2014-08-19 Yeda Research And Development Co. Ltd. Methods of generating mature oligodendrocytes
CA2662323A1 (fr) * 2006-09-08 2008-03-13 Wisconsin Alumni Research Foundation Analyse pour les anticorps envers le bacille de koch
US20100129656A1 (en) 2006-10-05 2010-05-27 Technion Research & Develpment Foundation Ltd Microtubes and methods of producing same
US7888059B2 (en) * 2006-10-05 2011-02-15 Yeda Research And Development Co. Ltd. Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
AU2007335706B2 (en) * 2006-12-20 2013-03-28 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7928083B2 (en) * 2007-01-16 2011-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem H19 silencing nucleic acid agents for treating rheumatoid arthritis
US20100196403A1 (en) * 2007-01-29 2010-08-05 Jacob Hochman Antibody conjugates for circumventing multi-drug resistance
US8911996B2 (en) 2007-01-31 2014-12-16 Technion Research & Development Foundation Limited Electrospun scaffolds and methods of generating and using same
CA2676932C (fr) 2007-02-01 2015-11-24 Technion Research & Development Foundation Ltd. Fibres et tissus d'albumine et leurs procedes de generation et d'utilisation
WO2008097866A2 (fr) 2007-02-02 2008-08-14 Baylor Research Institute Vaccins à base d'antigène cible au dcir exprimé dans des cellules présentant un antigène
AU2008214077B2 (en) * 2007-02-02 2012-12-13 Baylor Research Institute Multivariable antigens complexed with targeting humanized monoclonal antibody
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
NZ595319A (en) * 2007-02-23 2012-09-28 Baylor Res Inst Activation of human antigen-presenting cells through clec-6
AU2008231242B2 (en) 2007-02-23 2013-01-31 Baylor Research Institute Therapeutic applications of activation of human antigen-presenting cells through Dectin-1
EP2132226B1 (fr) 2007-02-23 2019-03-27 Baylor Research Institute Activation de cellules humaines presentant un antigene par l'intermediaire du recepteur ldl 1 oxyde de type lectine (lox-1) de cellules dendritiques
US8748371B2 (en) 2007-02-28 2014-06-10 Yeda Research And Development Co. Ltd. Nuclear targeting sequences
EP2514766A3 (fr) 2007-03-29 2013-06-05 Technion Research & Development Foundation Ltd. Anticorps, procédés et kits pour diagnostiquer et traiter un mélanome
WO2008120216A1 (fr) 2007-04-02 2008-10-09 Ramot At Tel Aviv University Ltd. Procédés permettant de détecter des cellules cancéreuses et leur utilisation pour diagnostiquer et surveiller le traitement de la maladie
BRPI0809796B1 (pt) * 2007-04-09 2021-09-08 Evogene Ltd Métodos para aumentar o teor de óleo, taxa de crescimento, biomassa, vigor e/ou rendimento de uma planta, e para produzir óleo
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
PL2144633T3 (pl) * 2007-04-23 2015-02-27 Sabag Rfa Ltd Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
EP3032259B1 (fr) 2007-05-01 2020-04-15 Tel Hashomer Medical Research Infrastructure and Services Ltd. Procédés de détection des cellules trophoblastiques dans le sang maternel sur la base de la cytokératine-7
DK2150276T3 (da) 2007-05-03 2014-08-18 Agency Science Tech & Res Antistoffer, som binder til et intracellulært prl-1- eller prl-3-polypeptid
EP2150608B1 (fr) 2007-05-07 2017-11-29 Protalix Ltd. Bioréacteur jetable à grande échelle
ATE540115T1 (de) 2007-07-11 2012-01-15 Yeda Res & Dev Nukleinsäurekonstruktsysteme mit fähigkeit zur diagnose oder behandlung eines zellzustands
JP2010533705A (ja) 2007-07-15 2010-10-28 ヒルマン，イチャク 抗菌ペプチドまたはその阻害剤を用いた疾病治療
IL184627A0 (en) 2007-07-15 2008-12-29 Technion Res & Dev Foundation Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
ES2685631T3 (es) 2007-07-24 2018-10-10 Evogene Ltd. Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o biomasa y/o rendimiento en plantas que los expresan
JP5312459B2 (ja) 2007-08-02 2013-10-09 ジリード バイオロジクス，インク． Ｌｏｘおよびｌｏｘｌ２阻害剤ならびにこれらの使用
WO2009022328A2 (fr) 2007-08-15 2009-02-19 Yeda Research And Development Co. Ltd. Régulateurs de la mmp-9 et leurs utilisations
CN101855549A (zh) 2007-09-12 2010-10-06 耶达研究及发展有限公司 在免疫豁免部位内治疗肿瘤的方法
US20090068669A1 (en) * 2007-09-12 2009-03-12 Elias Georges Slc9a3r1 directed diagnostics for neoplastic disease
WO2009037690A1 (fr) 2007-09-19 2009-03-26 Pluristem Ltd. Cellules adhérentes provenant de tissus adipeux ou placentaires et leur utilisation thérapeutique
EP2210092B1 (fr) 2007-10-19 2014-06-11 Rappaport Family Institute for Research in the Medical Sciences Compositions comprenant des sémaphorines pour le traitement de maladies associées à l'angiogenèse et leurs procédés de sélection
US9138470B2 (en) * 2007-11-02 2015-09-22 The Johns Hopkins University Multi-component L2 vaccine for prevention of human papilloma virus infection
WO2009069123A2 (fr) 2007-11-26 2009-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions renfermant des polypeptides fibreux et des polysaccharides
WO2009083958A2 (fr) 2007-12-27 2009-07-09 Evogene Ltd. Peptides isolés, polynucléotides utiles pour modifier l'efficacité d'utilisation de l'eau, l'efficacité d'utilisation d'engrais, la tolérance aux stress biotiques/abiotiques, le rendement et la biomasse dans des plantes
US20090233295A1 (en) * 2008-01-29 2009-09-17 Elias Georges Trim59 directed diagnostics for neoplastic disease
WO2009095925A2 (fr) * 2008-01-31 2009-08-06 Compugen Ltd. Polypeptides et polynucléotides et leurs utilisations en tant que cible médicamenteuse pour produire des médicaments et des produits biologiques
WO2009104176A2 (fr) 2008-02-21 2009-08-27 Technion Research & Development Foundation Ltd. Méthodes de liaison d'une molécule d'intérêt à un microtube
CA2718107A1 (fr) * 2008-03-18 2009-09-24 Wisconsin Alumini Research Foundation Test de criblage de culture mycobacterienne pour une bacterie complexe de mycobacterium avium
WO2009125394A1 (fr) * 2008-04-09 2009-10-15 Technion Research & Development Foundation Ltd. Anticorps anti-immunodéficience humaine et leurs utilisations
EP2297200A1 (fr) * 2008-04-09 2011-03-23 Technion Research & Development Foundation Ltd. Anticorps antigrippe et leurs utilisations
WO2009125381A1 (fr) * 2008-04-10 2009-10-15 Objet Geometries Ltd. Système et procédé pour l’impression de modèles en trois dimensions
CN102056619A (zh) 2008-04-18 2011-05-11 科尔普兰特有限公司 产生和使用原胶原的方法
EP2268129B1 (fr) 2008-04-21 2015-06-17 Danziger Innovations Ltd. Vecteurs d'expression de virus végétaux et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
TR201808744T4 (tr) * 2008-05-22 2018-07-23 Evogene Ltd İzole polinükleotidler ve polipeptidlerle bunların bitki yararını artırmaya yönelik kullanımına ilişkin yöntemler.
RU2515156C2 (ru) 2008-05-27 2014-05-10 Плуристем Лтд. Способы лечения воспалительных заболеваний ободочной кишки
EP2285951B1 (fr) 2008-05-28 2018-07-04 Ramot at Tel-Aviv University Ltd. Cellules souches mésenchymateuses destinées au traitement de troubles du snc
WO2010007613A1 (fr) 2008-06-29 2010-01-21 Realbio Technologies Ltd. Dispositif de transfert de liquide particulièrement utile comme dispositif de capture dans un processus de dosage biologique
MX343490B (es) 2008-07-16 2016-11-08 Inst For Res In Biomedicine Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos.
NZ594540A (en) 2008-07-16 2012-01-12 Baylor Res Inst Hiv vaccine based on targeting maximized gag and nef antigen to dendritic cells using antibodies
MX2011000542A (es) 2008-07-16 2011-08-03 Humabs Llc Citomegalovirus humano que neutraliza anticuerpos y su uso.
WO2010010467A2 (fr) * 2008-07-25 2010-01-28 Institute For Research In Biomedicine Anticorps neutralisant anti-virus influenza a et leurs utilisations
US8871207B2 (en) 2008-07-25 2014-10-28 Humabs, LLC Neutralizing anti-influenza A virus antibodies and uses thereof
US9580513B2 (en) 2008-08-08 2017-02-28 Agency For Science, Technology And Research (A*Star) VHZ for diagnosis and treatment of cancers
EP2657342B1 (fr) 2008-08-08 2015-11-18 Genisphere, LLC Dendrimères d'ADN protégés contre la dégradation par les nucléases
BR122021014158B1 (pt) * 2008-08-18 2022-08-16 Evogene Ltd. Método para aumentar a eficiência de uso do nitrogênio, e/ou tolerância à deficiência de nitrogênio de uma planta
AU2009288781B2 (en) 2008-09-02 2015-01-29 Pluri Biotech Ltd Adherent cells from placenta tissue and use thereof in therapy
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
EP2326340A4 (fr) 2008-09-11 2013-01-23 Univ Ben Gurion Compositions et procédés destinés à traiter une infection par s. pneumoniae
RU2535966C2 (ru) 2008-09-12 2014-12-20 Криопрашис Криобиоложия Лтда. Клеточная терапия ишемической ткани
JP5676451B2 (ja) 2008-09-24 2015-02-25 テル ハショメール メディカル リサーチ，インフラストラクチャ アンド サービシーズ リミテッド ペプチド
CA2736729A1 (fr) 2008-09-29 2010-04-01 Ben Gurion University Of The Negev Research And Development Authority Beta-peptides amyloides et procedes d'utilisation associes
JP2012504660A (ja) 2008-10-06 2012-02-23 ユニバーシティ オブ シカゴ 細菌ｅａｐ、ｅｍｐおよび／またはａｄｓａタンパク質に関連する組成物および方法
AR074071A1 (es) * 2008-10-30 2010-12-22 Evogene Ltd Polinucleotidos y polipeptidos aislados y metodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estres abiotico de las plantas y eficacia en el uso de nitrogeno
US20110229892A1 (en) 2008-11-17 2011-09-22 Yehuda G Assaraf Method for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (fr) 2008-11-19 2010-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
WO2010061383A1 (fr) 2008-11-26 2010-06-03 Biodalia Microbiological Technologies Ltd. Procédé permettant d’enrichir in-situ des aliments avec des fructanes
WO2010064231A1 (fr) 2008-12-02 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
US20120014927A1 (en) 2008-12-03 2012-01-19 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for determining predisposition to cancer
WO2010064248A2 (fr) 2008-12-05 2010-06-10 Yeda Research And Development Co. Ltd. Procédés de diagnostic et de traitement des maladies des motoneurones
WO2010071610A1 (fr) 2008-12-19 2010-06-24 Agency For Science, Technology And Research (A*Star) Marqueurs biologiques de chikungunya sévère
AR074925A1 (es) 2008-12-29 2011-02-23 Evogene Ltd Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para modular la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan
SG10201401054YA (en) 2008-12-29 2014-07-30 Tel Hashomer Medical Res Infrastructure & Services Ltd Peptides and compositions for prevention of cell adhesion and methods of using same
EP2808402A3 (fr) 2008-12-29 2015-03-25 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Méthodes de prédiction de la réponse au traitement par interférons
US8455263B2 (en) 2008-12-30 2013-06-04 Jin Po Lee Quantitative analyte assay device and method
WO2010076794A1 (fr) 2008-12-31 2010-07-08 Technion Research & Development Foundation Ltd. Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
US9107935B2 (en) * 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
IL196820A0 (en) 2009-02-01 2009-11-18 Yissum Res Dev Co Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
WO2010086867A2 (fr) 2009-02-02 2010-08-05 Ramot At Tel Aviv University Ltd. Peptides, compositions pharmaceutiques en contenant et leurs utilisations
WO2010089707A1 (fr) 2009-02-04 2010-08-12 Yeda Research And Development Co. Ltd. Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
WO2010097793A2 (fr) 2009-02-26 2010-09-02 Tel Hashomer Medical Research Infrastructure And Services Ltd. Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
SI3460062T1 (sl) 2009-03-02 2021-09-30 Evogene Ltd. Izolirani polinukleotidi in polipeptidi in postopki uporabe le-teh za zvišanje donosa in/ali poljedelskih značilnosti rastlin
EP3026057A3 (fr) 2009-03-09 2016-08-31 Ramot at Tel Aviv University Ltd. Compositions pour la prévention et le traitement de maladies neurodégénératives
WO2010103517A1 (fr) 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
EP2414542B1 (fr) 2009-03-30 2017-08-30 Tel HaShomer Medical Research Infrastructure and Services Ltd. Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
CA2759201A1 (fr) 2009-04-01 2010-10-07 The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical Center Procede de regulation de la proliferation et de la differenciation des keratinocytes
KR20170102039A (ko) 2009-04-03 2017-09-06 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
WO2010116375A1 (fr) 2009-04-08 2010-10-14 Yeda Research And Development Co. Ltd. Peptides isolés pour réguler l'apoptose
KR20180077322A (ko) 2009-04-30 2018-07-06 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． 항-ｃｅａｃａｍ1 항체들과 이를 이용하는 방법들
WO2010134073A1 (fr) 2009-05-19 2010-11-25 Zetiq Technologies Ltd. Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
WO2010135663A2 (fr) 2009-05-21 2010-11-25 The United States Of America , As Represented By The Secretary, Department Of Health And Human Services Compositions et procédés pour détecter une infection par le vih-1/vih-2
US20120078163A1 (en) 2009-05-27 2012-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of generating connective tissue
WO2010137017A2 (fr) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd. Inhibiteurs des protéasomes et leurs utilisations
WO2010137013A1 (fr) 2009-05-27 2010-12-02 Ramot At Tel Aviv University Ltd. Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
US20120070449A1 (en) 2009-05-28 2012-03-22 Yeda Research And Development Co. Ltd. Methods of treating inflammation
CA3095630A1 (fr) 2009-06-10 2010-12-16 Evogene Ltd. Polynucleotides et polypeptides isoles, et procedes d'utilisation de ceux-ci pour augmenter l'efficacite d'utilisation de l'azote, le rendement, le taux de croissance, la vigueur, la biomasse, la teneur en huile, et//ou la tolerance au stress abiotique
CA2765779A1 (fr) 2009-06-24 2010-12-29 Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center Methodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
WO2011004379A1 (fr) 2009-07-10 2011-01-13 Tel Hashomer Medical Research Infrastructure And Services Ltd. Compositions et méthodes de traitement du cancer
AU2010274581B2 (en) 2009-07-21 2014-05-01 Tel Hashomer Medical Research Infrastructure And Services Ltd. A method of diagnosing cancer
GB0913442D0 (en) 2009-07-31 2009-09-16 Univ Ramot Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
EP2467470A2 (fr) 2009-08-17 2012-06-27 Technion Research & Development Foundation Ltd. Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
RU2012110587A (ru) * 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Терапевтические способы и композиции
AU2010284000A1 (en) * 2009-08-21 2012-03-22 Gilead Biologics, Inc. In vitro screening assays
AU2010284036B2 (en) 2009-08-21 2014-12-18 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2
MX2012002189A (es) 2009-08-21 2012-03-16 Beeologics Inc Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
WO2011022670A1 (fr) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc Essais de criblage in vivo
RU2561672C2 (ru) * 2009-08-21 2015-08-27 Джилид Байолоджикс, Инк. Способы и композиции для лечения фиброзных заболеваний легких
US9642817B2 (en) 2009-08-27 2017-05-09 Technion Research & Development Foundation Limited Liposomal compositions and uses of same
WO2011030336A1 (fr) 2009-09-08 2011-03-17 Ramot At Tel-Aviv University Ltd. Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
US9610331B2 (en) 2009-09-08 2017-04-04 Yeda Research And Development Co. Ltd. Methods for hematopoietic precursor mobilization
US20120171213A1 (en) 2009-09-10 2012-07-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of treating tumors
WO2011033506A2 (fr) 2009-09-17 2011-03-24 Yeda Research And Development Co. Ltd. Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
JP2013505230A (ja) 2009-09-17 2013-02-14 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 酸化ストレス関連障害を処置するためのペプチド
US8735124B2 (en) 2009-09-17 2014-05-27 Yeda Research And Development Co. Ltd. Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
EP2488646B1 (fr) 2009-10-14 2017-12-06 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions pour lutter contre les acariens varroa chez l'abeille
US9109206B2 (en) 2009-10-16 2015-08-18 Rutgers, The State University Of New Jersey Method for treating chronic nerve tissue injury using a cell therapy strategy
WO2011048600A1 (fr) 2009-10-21 2011-04-28 Danziger Innovations Ltd. Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
IL201999A (en) 2009-11-08 2017-10-31 Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
US8962561B2 (en) 2009-11-12 2015-02-24 Ramot At Tel-Aviv University Ltd. Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
WO2011058555A1 (fr) 2009-11-12 2011-05-19 Yeda Research And Development Co. Ltd. Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
ES2932664T3 (es) 2009-11-12 2023-01-23 Technion Res & Dev Foundation Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado
WO2011061736A1 (fr) 2009-11-17 2011-05-26 Protalix Ltd. Alpha galactosidase alcaline pour le traitement de la maladie de fabry
US20130183326A9 (en) 2009-11-20 2013-07-18 St. Jude Children's Research Hospital Methods and compositions for modulating the activity of the interleukin-35 receptor complex
US20120273993A1 (en) 2009-11-24 2012-11-01 Collplant Ltd. Method of generating collagen fibers
WO2011064669A2 (fr) 2009-11-30 2011-06-03 Pluristem Ltd. Cellules adhérentes du placenta et leur utilisation dans le traitement de pathologies
US9562235B2 (en) 2009-12-06 2017-02-07 A.B. Seeds Ltd. MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
EP2510098B1 (fr) 2009-12-09 2015-02-11 Quark Pharmaceuticals, Inc. Méthodes et compositions utilisées pour le traitement de maladies, d'affections ou de lésions du snc
WO2011080674A2 (fr) 2009-12-28 2011-07-07 Evogene Ltd. Polynucléotides isolés et polypeptides et procédés pour les utiliser afin d'augmenter le rendement des cultures, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique des plantes et l'efficacité d'utilisation de l'azote
EP3184109B1 (fr) 2009-12-29 2020-11-18 Gamida-Cell Ltd. Procédés d'amplification de la prolifération et de l'activité des cellules tueuses naturelles
WO2011083464A2 (fr) 2010-01-05 2011-07-14 Vascular Biogenics Ltd. Procédés pour l'utilisation d'un agent adénoviral antiangiogenèse spécifique
SG10201500015TA (en) 2010-01-12 2015-02-27 Vascular Biogenics Ltd Methods of producing adenovirus vectors and viral preparations generated thereby
CA2787311C (fr) 2010-01-27 2017-08-15 Yeda Research And Development Co. Ltd. Anticorps inhibant les metalloproteines
SG183174A1 (en) 2010-02-04 2012-09-27 Gilead Biologics Inc Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
US9410131B2 (en) 2010-02-11 2016-08-09 Yeda Research And Development Co. Ltd. Enzymatic systems for carbon fixation and methods of generating same
US10080799B2 (en) 2010-02-12 2018-09-25 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
EP2538961B1 (fr) 2010-02-24 2016-10-12 Ben Gurion University Of The Negev Research And Development Authority Inhibition de la nécrose
WO2011107939A1 (fr) 2010-03-01 2011-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
WO2011107994A1 (fr) 2010-03-04 2011-09-09 Yeda Research And Development Co. Ltd. Procédés de mesure de la stabilité d'une protéine
US20130047297A1 (en) 2010-03-08 2013-02-21 Robert D. Sammons Polynucleotide molecules for gene regulation in plants
WO2011111034A1 (fr) 2010-03-08 2011-09-15 Yeda Research And Development Co. Ltd. Production de protéines recombinantes dans des systèmes hétérologues
CN102918159A (zh) 2010-03-11 2013-02-06 雅各布·埃德尔 产生氢的方法
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
US9073990B2 (en) 2010-04-05 2015-07-07 Bar-Llan University Protease-activatable pore-forming polypeptides
US8927274B2 (en) 2010-04-12 2015-01-06 Technion Research & Development Foundation Limited Populations of pancreatic progenitor cells and methods of isolating and using same
WO2011128895A2 (fr) 2010-04-12 2011-10-20 Ben Gurion University Of The Negev Research And Development Authority Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
WO2011132182A1 (fr) 2010-04-18 2011-10-27 Yeda Research And Development Co. Ltd. Molécules et méthodes d'utilisation de celles-ci pour le traitement des maladies associées aux ligands erbb/erbb
US9328353B2 (en) 2010-04-28 2016-05-03 Evogene Ltd. Isolated polynucleotides and polypeptides for increasing plant yield and/or agricultural characteristics
WO2011138778A2 (fr) 2010-05-04 2011-11-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés permettant d'identifier des inhibiteurs de polypeptides d'intérêt
EP2566500B1 (fr) 2010-05-05 2017-04-12 Rappaport Family Institute for Research in the Medical Sciences Ccl1 pour son utilisation thérapeutique
IL208820A0 (en) 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
WO2011141914A1 (fr) 2010-05-13 2011-11-17 Tel Hashomer Medical Research Infrastructure And Services Ltd. Populations isolées de cellules rénales adultes et procédés d'isolement et d'utilisation desdites populations
CN103037891A (zh) 2010-06-03 2013-04-10 雷蒙特亚特特拉维夫大学有限公司 治疗糖尿病的方法和能够治疗糖尿病的组合物
US20130316351A1 (en) 2010-06-07 2013-11-28 Osnat Ashur-Fabian Methods and kits for diagnosing conditions related to hypoxia
WO2011158242A2 (fr) 2010-06-16 2011-12-22 Futuragene Israel Ltd. Plantes résistantes aux organismes nuisibles
WO2011158243A2 (fr) 2010-06-16 2011-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de diagnostic et de traitement du cancer
KR20130093084A (ko) 2010-07-02 2013-08-21 더 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
EP2593468B1 (fr) 2010-07-12 2020-06-10 The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Polynucléotides isolés et procédés et plantes les utilisant pour la régulation de l'acidité des plantes
CA2805478A1 (fr) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Entites de haute affinite isolees presentant une specificite de type recepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigeniques associes au diabete
BR112013000984A2 (pt) 2010-07-15 2017-10-03 Technion Res & Dev Foundation Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
US9695410B2 (en) 2010-07-15 2017-07-04 Technion Research & Development Foundation Limited Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
US9624469B2 (en) 2010-07-22 2017-04-18 Cellect Biotherapeutics Ltd. Regulatory immune cells with enhanced targeted cell death effect
WO2012014205A1 (fr) 2010-07-27 2012-02-02 Technion Research & Development Foundation Ltd. Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
WO2012014208A2 (fr) 2010-07-27 2012-02-02 Yeda Research And Development Co. Ltd. Procédés et systèmes d'estimation de la clonalité de cultures cellulaires
US20130130387A1 (en) 2010-07-27 2013-05-23 Technion Research & Development Foundation Limited Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
WO2012017439A2 (fr) 2010-08-04 2012-02-09 Ramot At Tel-Aviv University Ltd. Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
EP2606122A1 (fr) 2010-08-22 2013-06-26 Ramot at Tel Aviv University, Ltd. Cellules souches pluripotentes induites dérivées de cellules bêta pancréatiques humaines
WO2012025925A1 (fr) 2010-08-24 2012-03-01 Rappaport Family Institute For Research In The Medical Sciences Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
AR082530A1 (es) 2010-08-30 2012-12-12 Evogene Ltd Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico
WO2012032519A2 (fr) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthodes de diagnostic de la maladie de parkinson
ES2746482T3 (es) 2010-09-07 2020-03-06 Technion Res & Dev Foundation Nuevos métodos y medios de cultivo para cultivar células madre pluripotentes
EP2613799A1 (fr) 2010-09-07 2013-07-17 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
WO2012032510A1 (fr) 2010-09-07 2012-03-15 Yeda Research And Development Co. Ltd. Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
ES2589678T3 (es) 2010-09-08 2016-11-15 Yeda Research And Development Co. Ltd. Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma
US20130183322A1 (en) 2010-09-08 2013-07-18 Yeda Research And Development Co., Ltd. Immunosuppressive drug combination for a stable and long term engraftment
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
EP2616539A1 (fr) 2010-09-15 2013-07-24 Ramot at Tel-Aviv University Ltd. Procédés d'expansion et de redifférenciation de cellules bêta des îlots
WO2012038956A1 (fr) 2010-09-20 2012-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de traitement de maladies neurodégénératives
US8951983B2 (en) 2010-10-17 2015-02-10 Yeda Research And Development Co. Ltd. Methods and compositions for the treatment of insulin-associated medical conditions
WO2012052878A1 (fr) 2010-10-19 2012-04-26 Vascular Biogenics Ltd. Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
US20130216603A1 (en) 2010-10-27 2013-08-22 Nanocyte (Israel) Ltd. Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
CN103370337B (zh) 2010-10-28 2015-12-09 耶达研究及发展有限公司 用于产生针对金属酶的抗体的方法
WO2012059922A2 (fr) 2010-11-03 2012-05-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Plantes transgéniques à rendements de saccharification améliorés, et procédé pour les générer
WO2012059925A2 (fr) 2010-11-04 2012-05-10 Ben-Gurion University Of The Negev Research And Development Authority Acyl-coa: gène de type diacylglycérol acyltransférase 1 (ptdgat1) et utilisations de celui-ci
TW201225972A (en) 2010-11-15 2012-07-01 Univ Ramot Dipeptide analogs for treating conditions associated with amyloid fibril formation
US10117895B2 (en) 2010-11-17 2018-11-06 Ben-Gurion University Of The Negev Research And Development Authority T-cell therapy to neurodegenerative diseases
WO2012075111A1 (fr) 2010-11-30 2012-06-07 Novartis Ag Utilisation d'anticorps anti-cd40 en thérapie combinée contre des cancers associés aux cellules b
EP2646543A4 (fr) 2010-12-02 2014-09-03 Technion Res & Dev Foundation Procédé de génération de cellules cornéennes et populations de cellules les comprenant
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
US9404087B2 (en) 2010-12-15 2016-08-02 Kadimastem Ltd. Insulin producing cells derived from pluripotent stem cells
MX344728B (es) 2010-12-22 2017-01-05 Evogene Ltd Polinucleótidos y polipéptidos aislados, y métodos para utilizarlos para aumentar la tolerancia al estrés abiótico, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o eficacia en el uso de nitrógeno de las plantas.
CN107648341A (zh) 2010-12-28 2018-02-02 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
JP5913372B2 (ja) 2011-01-20 2016-04-27 プロタリクス リミテッド 植物および植物細胞におけるα−ガラクトシダーゼの発現のための核酸発現構築物
US20130316358A1 (en) 2011-01-31 2013-11-28 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
US20130330349A1 (en) 2011-02-23 2013-12-12 Rappaport Family Institute For Research In The Medical Sciences High affinity molecules capable of binding a type a plexin receptor and uses of same
EP2492279A1 (fr) 2011-02-25 2012-08-29 Laboratorios Del. Dr. Esteve, S.A. Procédé de sélection rapide d'immunogène par expression à la surface du lentivirus.
CN103597078B (zh) 2011-03-02 2016-12-14 富途锐基尼以色列有限公司 具有功能失调的t3ss蛋白的抗菌性转基因植物
EP2680864B1 (fr) 2011-03-03 2019-05-08 Ramot at Tel-Aviv University Ltd. Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
US9574003B2 (en) 2011-03-06 2017-02-21 Merck Serono S.A. Low fucose cell lines and uses thereof
WO2012120518A1 (fr) 2011-03-08 2012-09-13 Ramot At Tel-Aviv University Ltd. Compositions et méthodes de diagnostic et de traitement de phénylcétonurie (pcu)
EP2685976B1 (fr) 2011-03-17 2017-12-27 Tel HaShomer Medical Research Infrastructure and Services Ltd. Analogues de quinolone pour le traitement de maladies auto-immunes
CA2827188C (fr) 2011-03-17 2020-02-11 Itai Benhar Anticorps asymetriques bi- et monospecifiques et leur procede de generation
EP2689008B1 (fr) 2011-03-22 2017-09-27 Pluristem Ltd. Procédés de traitement de blessures dues aux expositions aux irradiations ou aux produits chimiques
CA2830792A1 (fr) 2011-03-24 2012-09-27 Neurim Pharmaceuticals (1991) Ltd. Peptides neuroprotecteurs
WO2012131680A2 (fr) 2011-03-28 2012-10-04 Yeda Research And Development Co. Ltd. Compositions et procédés pour le traitement de l'inflammation
WO2012137202A1 (fr) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
AU2012240953B2 (en) 2011-04-06 2017-02-23 Ramot At Tel-Aviv University Ltd. Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
US9150644B2 (en) 2011-04-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
AU2012241521B2 (en) 2011-04-15 2016-07-14 Pluri Biotech Ltd Methods and systems for harvesting cells
BR122020018202B1 (pt) 2011-05-03 2022-02-08 Evogene Ltd Método para aumentar o rendimento, biomassa, taxa de crescimento, vigor, e/ou eficiência no uso de nitrogênio de uma planta
EP2704793B1 (fr) 2011-05-04 2019-07-17 Ramot at Tel Aviv University, Ltd. Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2012153333A1 (fr) 2011-05-09 2012-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
WO2012153336A2 (fr) 2011-05-12 2012-11-15 Rakuto Bio Technologies Ltd. Procédés et dispositifs pour éclaircir la carnation de la peau
WO2012156976A1 (fr) 2011-05-16 2012-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
WO2012160526A2 (fr) 2011-05-23 2012-11-29 Ofir Menashe Formulations à base de particules contenant des micro-organismes et leurs utilisations
US20140088017A1 (en) 2011-05-23 2014-03-27 Yeda Research And Development Co., Ltd. Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2012164380A2 (fr) 2011-05-31 2012-12-06 Hutchison Biofilm Medical Solutions Limited Dispersion et détachement d'agrégats cellulaires
WO2012164565A1 (fr) 2011-06-01 2012-12-06 Yeda Research And Development Co. Ltd. Compositions et procédés pour la régulation à la baisse de gènes procaryotes
US10166295B2 (en) 2011-06-02 2019-01-01 Opko Biologics Ltd. Pegylated OXM variants
ES2670596T3 (es) 2011-06-14 2018-05-31 Yeda Research And Development Co. Ltd. Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
JP2014523240A (ja) 2011-06-23 2014-09-11 カイイマ バイオ アグリテック リミテッド 部分的多重ゲノムまたは完全多重ゲノムを有する普通コムギ、その植物体または一部分、そのハイブリッドおよび生成物、ならびに、それらの作製方法および使用方法
PL3418300T3 (pl) 2011-07-18 2021-05-04 Institute For Research In Biomedicine Neutralizujące przeciwciała przeciwko wirusowi grypy A i ich zastosowania
BR112014001348A2 (pt) 2011-07-20 2017-07-18 Kaiima Bio Agritech Ltd plantas de milho parcial ou totalmente multiplicado e usos respectivos
EP2550982A1 (fr) 2011-07-27 2013-01-30 Technion Research & Development Foundation Ltd. Dispositifs pour applications chirurgicales
EP3208338B1 (fr) 2011-08-04 2019-04-10 Yeda Research and Development Co., Ltd. Micro-arn mir-15 et compositions les comprenant pour le traitement de troubles médicaux associés à l'hormone de libération de la corticotropine
EP2741753A2 (fr) 2011-08-09 2014-06-18 Yeda Research and Development Co. Ltd. Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
AR087524A1 (es) 2011-08-14 2014-03-26 Kaiima Bio Agritech Ltd Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos
WO2013035070A1 (fr) 2011-09-07 2013-03-14 Yeda Research And Development Co. Ltd. Signature olfactive et mélange odorant la contenant
SG11201400513PA (en) 2011-09-08 2014-06-27 Yeda Res & Dev Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
WO2013035071A1 (fr) 2011-09-08 2013-03-14 Yeda Research And Development Co. Ltd. Nouveaux biomarqueurs de risque pour le cancer du poumon
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
EP3382027A3 (fr) 2011-09-13 2018-10-31 Monsanto Technology LLC Procédés et compositions de lutte contre les mauvaises herbes
CA2848695A1 (fr) 2011-09-13 2013-03-21 Monsanto Technology Llc Procede et composition de lutte contre les mauvaises herbes comprenant l'inhibition de la ppg oxydase
AU2012308694B2 (en) 2011-09-13 2018-06-14 Monsanto Technology Llc Methods and compositions for weed control
CN107739737A (zh) 2011-09-13 2018-02-27 孟山都技术公司 用于杂草控制的方法和组合物
WO2013054320A1 (fr) 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
JP6844939B2 (ja) 2011-10-21 2021-03-17 オ−グレックス ライフ サイエンシズ コーポレイション シトルリン化１４−３−３由来の抗原、及び関節リウマチの診断におけるそれの使用
WO2013061328A2 (fr) 2011-10-27 2013-05-02 Yeda Research And Development Co. Ltd. Procédé de traitement du cancer
AU2012332517B9 (en) 2011-11-03 2017-08-10 Quark Pharmaceuticals, Inc. Methods and compositions for neuroprotection
US20140323549A1 (en) 2011-11-08 2014-10-30 Quark Pharmaceuticals, Inc. Methods and compositions for treating diseases, disorders or injury of the nervous system
US9736998B2 (en) 2011-11-23 2017-08-22 Danziger Dan Flower Farm Otomeria plants
US9617331B2 (en) 2011-11-27 2017-04-11 Yeda Research And Development Co. Ltd. Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
PT2788009T (pt) 2011-12-08 2016-08-31 Yeda Res & Dev Células pulmonares fetais de mamíferos e uso terapêutico das mesmas
WO2013093921A1 (fr) 2011-12-20 2013-06-27 Collplant Ltd. Fibres de polymère synthétique enrobées de collagène
CN105833925B (zh) 2011-12-22 2018-11-13 瑞尔比奥技术有限公司 用于分析物测定的序贯侧向流动毛细管装置
WO2013093919A2 (fr) 2011-12-22 2013-06-27 Yeda Research And Development Co. Ltd. Polythérapie mise en oeuvre pour obtenir une prise de greffe stable et à long terme au moyen de protocoles spécifiques d'appauvrissement des lymphocytes t/b
MX2014008083A (es) 2011-12-28 2015-03-19 Kaiima Bio Agritech Ltd Una planta de sorgo cultivada que tiene un genoma parcial o totalmente multiplicado y usos de la misma.
US20150216998A1 (en) 2012-01-01 2015-08-06 Ramot At Tel-Aviv University Ltd. Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
WO2013114363A2 (fr) 2012-01-30 2013-08-08 Yeda Research And Development Co.Ltd. Agents antimicrobiens
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
US10184131B2 (en) 2012-02-06 2019-01-22 A.B. Seeds Ltd. Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
KR102310704B1 (ko) 2012-02-14 2021-10-08 옵코 바이오로직스 리미티드 장기 작용 응고 인자들 및 이를 생산하는 방법들
WO2013121405A1 (fr) 2012-02-19 2013-08-22 Protalix Ltd. Formes galéniques unitaires administrées par voie orale et utilisations de celles-ci pour le traitement de la maladie de gaucher
JP2015509366A (ja) 2012-02-22 2015-03-30 ブレインステム バイオテック リミテッド 神経幹細胞および運動ニューロンの生成
EP2844744A2 (fr) 2012-02-22 2015-03-11 Brainstem Biotec Ltd. MicroARN POUR LA GÉNÉRATION D'ASTROCYTES
US20150101074A1 (en) 2012-03-01 2015-04-09 The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
EP3483184A1 (fr) 2012-03-07 2019-05-15 Yeda Research and Development Co. Ltd Compositions inhibitrices de la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
BR112014023063A2 (pt) 2012-03-20 2017-07-18 Corti Davide anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos
US9334308B2 (en) 2012-03-22 2016-05-10 Ramot At Tel-Aviv University Ltd. PLIF multimeric peptides and uses thereof
US9283272B2 (en) 2012-03-30 2016-03-15 The United States Of America As Represented By The Department Of Veterans Affairs Targeting intracellular target-binding determinants with intracellular antibodies
CN104271749A (zh) 2012-04-18 2015-01-07 雷蒙特亚特特拉维夫大学有限公司 用于递送核酸的脂化的糖胺聚糖颗粒
PE20142405A1 (es) 2012-04-19 2015-01-25 Opko Biolog Ltd Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
EP3805395A1 (fr) 2012-04-26 2021-04-14 University Of Chicago Antigènes des staphylocoques coagulase et leurs méthodes d'utilisation
ES2627816T3 (es) 2012-05-09 2017-07-31 Yeda Research And Development Co. Ltd. Variantes del pro-dominio de tace como inhibidor de TNF-a y su uso médico
US8865158B2 (en) 2012-05-22 2014-10-21 Ramot At Tel-Aviv University Ltd. Bacteriophages for reducing toxicity of bacteria
MX369626B (es) 2012-05-24 2019-11-13 Mountgate Group Ltd Composiciones y metodos relacionados con la prevencion y el tratamiento de infecciones por rabia.
AR091143A1 (es) 2012-05-24 2015-01-14 Seeds Ltd Ab Composiciones y metodos para silenciar la expresion genetica
WO2013183048A1 (fr) 2012-06-03 2013-12-12 Ben-Gurion University Of The Negev Research And Development Authority Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
CN109096387B (zh) 2012-06-04 2021-11-30 奥普科生物制品有限公司 聚乙二醇化的oxm变体
US10023474B2 (en) 2012-07-03 2018-07-17 Nanospun Technologies Ltd. Methods for adsorption and biodegradation of petroleum
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
DK2880155T3 (da) 2012-07-29 2019-07-15 Yeda Res & Dev Anvendelse af den reduktive glycinvej til generering af formatotrofiske og autotrofiske mikroorganismer
WO2014020608A1 (fr) 2012-07-31 2014-02-06 Yeda Research And Development Co. Ltd. Procédés de diagnostic et de traitement de maladies du neurone moteur
CA2877223C (fr) 2012-08-06 2019-08-27 Brainstorm Cell Therapeutics Ltd. Procedes de generation de cellules souches mesechymateuses qui secretent des facteurs neurotrophiques
EP2698377A1 (fr) 2012-08-17 2014-02-19 Laboratorios Del. Dr. Esteve, S.A. Procédé de sélection rapide d'immunogène de variants de la GP-120 du VIH amélioré
AR092868A1 (es) 2012-09-03 2015-05-06 A B Seeds Ltd Metodo para mejorar la tolerancia al estres abiotico de plantas y plantas generadas mediante dicho metodo
WO2014041544A1 (fr) 2012-09-12 2014-03-20 Ramot At Tel-Aviv University Ltd. Immunoparticules et procédés pour les produire et les utiliser
US9701719B2 (en) 2012-09-27 2017-07-11 Research Development Foundation Attenuated Chikungunya virus
WO2014057490A1 (fr) 2012-10-09 2014-04-17 Ramot At Tel-Aviv University Ltd. Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
EP2912062A1 (fr) 2012-10-24 2015-09-02 Yeda Research and Development Co. Ltd. Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
WO2014068553A1 (fr) 2012-10-29 2014-05-08 Yeda Research And Development Co. Ltd. Aptamères, aptamères multimères et leurs utilisations
SG10202010383YA (en) 2012-11-20 2020-11-27 Opko Biologics Ltd Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
KR20150090116A (ko) 2012-11-29 2015-08-05 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 종양 전이를 예방하고, 암을 치료하고 예후를 예측하며, 추정상의 전이 억제인자 물질을 확인하는 방법
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
BR112015015976A2 (pt) 2013-01-01 2018-04-10 A. B. Seeds Ltd. método para introduzir dsrna em sementes para modular a expressão genética
WO2014108850A2 (fr) 2013-01-09 2014-07-17 Yeda Research And Development Co. Ltd. Analyse de transcriptome à haut débit
WO2014108854A1 (fr) 2013-01-09 2014-07-17 Fusimab Ltd. Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
JP6411372B2 (ja) 2013-01-17 2018-10-24 ノベルラスディクス リミテッド 患者特有のドライバー変異を特定するための方法およびシステム
WO2014118785A1 (fr) 2013-02-04 2014-08-07 Ramot At Tel-Aviv University Ltd. Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
BR112015021707A2 (pt) 2013-03-06 2017-12-05 Hadasit Med Res Service uso de células de planta que expresam um inibidor de polipeptídeo tnfalfa em terapia.
BR112015021708A2 (pt) 2013-03-06 2017-08-29 Protalix Ltd Inibidor de polipetídeo do tnfa, polinucleotídeo isolado, estrutura de expressão de ácido nucleico, célula de planta, composição farmacêutica e método de produção de um inibidor de polipeptídeo do tnfa
WO2014138696A1 (fr) 2013-03-07 2014-09-12 University Of Maryland, Baltimore Potentiel immunothérapeutique de lipooligosaccharides/lipide a modifiés
AU2014248958A1 (en) 2013-03-13 2015-10-01 Monsanto Technology Llc Methods and compositions for weed control
EP3604535A3 (fr) 2013-03-13 2020-04-22 Monsanto Technology LLC Procédés et compositions utilisables pour lutter contre les mauvaises herbes
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
CN105263511A (zh) 2013-03-21 2016-01-20 科尔普兰特有限公司 用于组织再生的包含胶原和prp的组合物
AU2014240733B2 (en) 2013-03-24 2018-11-22 Biolinerx Ltd. Methods of treating myeloid leukemia
BR112015026702A2 (pt) 2013-04-21 2018-02-06 Yeda Res And Developmente Co Ltd métodos de extermínio de células senescentes
CN105531365A (zh) 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
EP2989119B1 (fr) 2013-04-25 2018-03-21 Yeda Research and Development Co., Ltd. Utilisation de peptides inhibiteurs pour le traitement de maladies inflammatoires
WO2014188423A1 (fr) 2013-05-21 2014-11-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Traitement de pathologies associées aux mastocytes
RU2015151047A (ru) 2013-05-27 2017-06-29 Ракуто Био Текнолоджис Лтд. Содержащие ферментную систему косметические композиции
EP3013380B1 (fr) 2013-06-24 2022-11-23 Ramot at Tel-Aviv University Ltd. Échafaudage à base d'épiploon et système d'administration
EP3608412A3 (fr) 2013-07-19 2020-04-08 Monsanto Technology LLC Compositions et méthodes de lutte contre leptinotarsa
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
WO2015015489A1 (fr) 2013-07-30 2015-02-05 Biolinerx Ltd. Anticorps convenant au traitement du diabète et de maladies autoimmunes
EP3039030B1 (fr) 2013-08-29 2018-09-19 Yeda Research and Development Co. Ltd. Inhibiteurs sélectifs de l'isoforme alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intra-oculaire
WO2015033343A1 (fr) 2013-09-03 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions et procédés utilisables en vue de l'expression de polypeptides recombinés
IL228284A (en) 2013-09-03 2016-12-29 Technion Res & Dev Foundation Implants from cellular scaffolding and blood vessel stalk
WO2015033344A1 (fr) 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
WO2015037009A1 (fr) 2013-09-16 2015-03-19 Plexicure Ltd. Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
ES2717446T3 (es) 2013-09-17 2019-06-21 Yeda Res & Dev Péptidos derivados de ERK y usos de los mismos
ES2796853T3 (es) 2013-10-01 2020-11-30 Kadimastem Ltd Diferenciación dirigida de astrocitos a partir de células madre pluripotentes humanas para uso en el cribado de medicamentos y el tratamiento de la esclerosis lateral amiotrófica (ELA)
CN105848722B (zh) 2013-10-02 2021-09-03 免疫医疗有限责任公司 中和抗甲型流感抗体及其用途
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
KR20160068969A (ko) 2013-10-21 2016-06-15 옵코 바이오로직스 리미티드 장시간-작용하는 폴리펩티드, 그의 생산 방법, 및 그의 투여 방법
US10767156B2 (en) 2013-10-24 2020-09-08 Yeda Research And Development Co., Ltd. Polynucleotides encoding BREX system polypeptides and methods of using same
US20160243187A1 (en) 2013-10-31 2016-08-25 Biokine Therapeutics Ltd. Methods of treating acute myeloid leukemia with a flt3 mutation
US9540642B2 (en) 2013-11-04 2017-01-10 The United States Of America, As Represented By The Secretary Of Agriculture Compositions and methods for controlling arthropod parasite and pest infestations
CA2925698C (fr) 2013-11-28 2021-11-09 Tel Hashomer Medical Research Infrastructure And Services Ltd. Inhibiteurs de l'arn polymerase i et leurs utilisations
EP3074044A2 (fr) 2013-11-28 2016-10-05 Yeda Research and Development Co., Ltd. Inhibiteurs de synaptojanine-2 et leurs utilisations
UA119253C2 (uk) 2013-12-10 2019-05-27 Біолоджикс, Інк. Спосіб боротьби із вірусом у кліща varroa та у бджіл
US10053712B2 (en) 2013-12-10 2018-08-21 Yeda Research And Development Co. Ltd. Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
WO2015108982A2 (fr) 2014-01-15 2015-07-23 Monsanto Technology Llc Procédés et compositions pour la lutte contre les mauvaises herbes utilisant des polynucléotides epsps
WO2015114633A1 (fr) 2014-01-30 2015-08-06 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
AU2015212341A1 (en) 2014-02-03 2016-09-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of Casein kinase I inhibitors for depleting stem cells
CA2936158C (fr) 2014-02-05 2023-06-13 Yeda Research And Development Co. Ltd. Utilisation de mir-135 ou un precurseur connexe pour le traitement ou le diagnostic d'un trouble bipolaire
ES2696348T3 (es) 2014-02-06 2019-01-15 Yeda Res & Dev Anticuerpos anti CD84, composiciones que comprenden los mismos y usos de los mismos
WO2015118547A1 (fr) 2014-02-10 2015-08-13 Protalix Ltd. Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
EP3105587B1 (fr) 2014-02-11 2023-09-06 Brainstorm Cell Therapeutics Ltd. Procédé de qualification de cellules
WO2015132784A1 (fr) 2014-03-03 2015-09-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé et dispositif de détection de pseudomonas aeruginosa
EP2923709A1 (fr) 2014-03-28 2015-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vaccin contre la malaria multi-composants-multi-étapes
WO2015153339A2 (fr) 2014-04-01 2015-10-08 Monsanto Technology Llc Compositions et procédés pour lutter contre les insectes nuisibles
EP3129075A4 (fr) 2014-04-10 2017-12-06 Bonus Therapeutics Ltd. Compositions pour la réparation des os
EP4306659A3 (fr) 2014-04-14 2024-03-27 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Procédé et kit pour déterminer l'origine tissulaire ou cellulaire d'adn
EP3132057B1 (fr) 2014-04-17 2019-10-16 Yeda Research and Development Co. Ltd. Procédés et kits pour analyser les fragments se liant à l'adn liés à l'adn
US11427647B2 (en) 2014-04-27 2022-08-30 Famewave Ltd. Polynucleotides encoding humanized antibodies against CEACAM1
MD20160130A2 (ro) 2014-04-27 2017-04-30 Ccam Biotherapeutics Ltd. Anticorpi umanizaţi contra CEACAM1
WO2015166492A2 (fr) 2014-04-28 2015-11-05 Yeda Research And Development Co. Ltd. Réponse du microbiome à des agents
WO2015170324A2 (fr) 2014-05-04 2015-11-12 Forrest Innovations Ltd. Compositions de lutte contre les moustiques et leurs utilisations
IL300029A (en) 2014-05-16 2023-03-01 Baylor Res Institute Methods and preparations for the treatment of autoimmune and inflammatory conditions
EP3145947A2 (fr) 2014-05-22 2017-03-29 Yeda Research and Development Co., Ltd. Micro-organismes recombinés pouvant fixer le carbone
WO2015186128A1 (fr) 2014-06-02 2015-12-10 Kadimastem Ltd. Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
US20170253881A1 (en) 2014-06-02 2017-09-07 Technion Research & Development Foundation Limited Compositions and methods of selectively inhibiting irp1 and treating inflammation
CN106795515B (zh) 2014-06-23 2021-06-08 孟山都技术公司 用于经由rna干扰调控基因表达的组合物和方法
US20170183376A1 (en) 2014-06-24 2017-06-29 Insight Biopharmaceuticals Ltd. Methods of purifying antibodies
EP3161138A4 (fr) 2014-06-25 2017-12-06 Monsanto Technology LLC Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
WO2015198334A2 (fr) 2014-06-25 2015-12-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Identification de cellules souches cancéreuses et utilisation de celles-ci pour des diagnostics et traitements
JP2017520549A (ja) 2014-06-26 2017-07-27 ラモット アット テル アビブ ユニバーシティ， リミテッド 核酸の送達のためのリポソーム製剤
WO2016005985A2 (fr) 2014-07-09 2016-01-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthode pour reprogrammer des cellules
BR112017000710B1 (pt) 2014-07-15 2024-02-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Polipeptídeo isolado, composição de matéria, e, uso do polipeptídeo isolado ou da composição da matéria
US10294292B2 (en) 2014-07-15 2019-05-21 Medimmune, Llc Neutralizing anti-influenza B antibodies and uses thereof
CA2955411A1 (fr) 2014-07-21 2016-01-28 Novellusdx Ltd. Procedes de determination d'une reponse a un medicament de mutations specifiques a un patient
JP6837428B2 (ja) 2014-07-21 2021-03-10 ノベルラスディクス リミテッド 患者特有の変異の発癌性指数を決定する方法およびシステム
UA125244C2 (uk) 2014-07-29 2022-02-09 Монсанто Текнолоджі Елелсі Спосіб умертвіння або припинення росту комахи
US11920164B2 (en) 2014-07-30 2024-03-05 Yeda Research And Development Co. Ltd. Media for culturing naive human pluripotent stem cells
KR20170041907A (ko) 2014-08-14 2017-04-17 메메드 다이어그노스틱스 리미티드 매니폴드 및 초평면을 이용한 생물학적 데이터의 컴퓨터 분석법
WO2016030899A1 (fr) 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Méthodes de traitement de la sclérose latérale amyotrophique
EP2992895A1 (fr) 2014-09-08 2016-03-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vaccin contre la malaria multi-composants-multi-étapes
EP3191523B1 (fr) 2014-09-08 2019-08-07 Yeda Research and Development Co., Ltd. Compositions et procédés de traitement d'un cancer résistant à un inhibiteur de la tyrosine kinase (tki)
US10526416B2 (en) 2014-09-08 2020-01-07 Yeda Research And Development Co. Ltd. Anti-HER3 antibodies and uses of same
IL234638A0 (en) 2014-09-14 2014-12-02 Yeda Res & Dev NMDA receptor antagonists for the treatment of Gaucher disease
EP3230453B1 (fr) 2014-09-21 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Freination du mir-132 pour le traitement de troubles lipidiques
WO2016055950A1 (fr) 2014-10-08 2016-04-14 Novartis Ag Combinaison d'anticorps de neutralistion du cytomégalovirus humain
EP3739062B1 (fr) 2014-10-20 2023-08-16 Gen-Probe Incorporated Solution de lyse cellulaire contenant des globules rouges
AU2015346969B2 (en) 2014-11-13 2019-03-21 Enzootic Holdings Ltd. Functional sex-reversal of decapod crustacean females
WO2016075546A2 (fr) 2014-11-14 2016-05-19 Antonio Lanzavecchia Anticorps qui neutralisent le virus ebola et leurs utilisations
EP3220945A2 (fr) 2014-11-17 2017-09-27 Yeda Research and Development Co., Ltd. Procédés de traitement de maladies associées à une fonction mitochondriale
WO2016079731A2 (fr) 2014-11-17 2016-05-26 Yeda Research And Development Co. Ltd. Procédé d'analyse de microbiome
WO2016078761A1 (fr) 2014-11-18 2016-05-26 Humabs Biomed Sa Anticorps à puissante activité de neutralisation du virus de la rage et d'autres lyssavirus et leurs utilisations
EA038931B9 (ru) 2014-11-20 2022-02-18 Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
WO2016084088A1 (fr) 2014-11-26 2016-06-02 Ramot At Tel-Aviv University Ltd. Élimination ciblée de gènes bactériens
WO2016084084A1 (fr) 2014-11-27 2016-06-02 Danziger Innovations Ltd. Construction d'acide nucléique pour l'édition de génome
US10688330B2 (en) 2014-12-11 2020-06-23 Yeda Research And Development Co. Ltd. Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
WO2016103269A1 (fr) 2014-12-23 2016-06-30 Ramot At Tel-Aviv University Ltd. Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
MX2017008818A (es) 2014-12-30 2018-03-14 Cell Cure Neurosciences Ltd Metodos para tratar enfermedades de la retina.
AU2015373050B2 (en) 2014-12-30 2022-09-29 Cell Cure Neurosciences Ltd. RPE cell populations and methods of generating same
CA2972580A1 (fr) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Evaluation de populations de cellules epitheliales pigmentaires retiniennes
RU2017125957A (ru) 2015-01-04 2019-02-04 Проталикс Лтд. Модифицированная днказа и ее применения
WO2016116935A1 (fr) 2015-01-21 2016-07-28 Yeda Research And Development Co. Ltd. Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
PL3256589T3 (pl) 2015-01-22 2022-02-21 Monsanto Technology Llc Kompozycje i sposoby kontrolowania leptinotarsa
US20180345047A1 (en) 2015-02-26 2018-12-06 Yeda Research And Development Co. Ltd. Method of promoting hair growth
US10781445B2 (en) 2015-03-11 2020-09-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Decoy oligonucleotides for the treatment of diseases
IL237852A0 (en) 2015-03-19 2016-03-24 Yeda Res & Dev Antibodies against amphigoline, medical preparations containing them and their use
EP3273971A4 (fr) 2015-03-27 2018-12-05 Yeda Research and Development Co. Ltd. Méthodes de traitement des maladies des motoneureones
ES2904573T3 (es) 2015-03-27 2022-04-05 Univ Southern California Terapia con células T dirigida a LHR para el tratamiento de tumores sólidos
EP3277308A1 (fr) 2015-03-31 2018-02-07 Yeda Research and Development Co., Ltd. Glutamate oxaloacétate transaminase 1 (got1), préparations, procédés de génération des préparations et utilisations des préparations
US10960035B2 (en) 2015-04-01 2021-03-30 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) Erodium crassifolium L'Her plant extracts and uses thereof
CN114716390A (zh) 2015-04-07 2022-07-08 Ela制药有限公司 用于治疗和/或预防细胞或组织坏死的组合物和方法
EP3081575A1 (fr) 2015-04-12 2016-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anticorps anti-plasmodium pour parasite
ES2951653T3 (es) 2015-04-27 2023-10-24 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Moléculas dirigidas a EGR1 para el tratamiento de afecciones inflamatorias e hiperproliferativas
ES2911341T3 (es) 2015-04-29 2022-05-18 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Composiciones antifitopatogénicas
WO2016174652A1 (fr) 2015-04-30 2016-11-03 Technion Research & Development Foundation Limited Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
CN108026566A (zh) 2015-05-04 2018-05-11 特拉维夫大学拉莫特有限公司 用于使dna片段化的方法和试剂盒
US20180161300A1 (en) 2015-05-11 2018-06-14 Yeda Research And Development Co., Ltd. Citrin inhibitors for the treatment of cancer
US11219636B2 (en) 2015-05-17 2022-01-11 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Compositions and methods for treating cancer
WO2016185457A1 (fr) 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Méthodes pour favoriser la lymphagiogenèse
WO2016185481A2 (fr) 2015-05-20 2016-11-24 Yeda Research And Development Co. Ltd. Procédé destiné à cibler des cellules sénescentes
MX2017014787A (es) 2015-05-21 2018-05-01 Yeda Res & Dev Poblaciones bacterianas para promover la salud.
WO2016193969A2 (fr) 2015-05-29 2016-12-08 Opko Biologics Ltd. Variantes de l'oxyntomoduline pégylée
HUE056407T2 (hu) 2015-06-01 2022-02-28 Medimmune Llc Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik
EP3302053B1 (fr) 2015-06-02 2021-03-17 Monsanto Technology LLC Compositions et procédés pour l'administration d'un polynucléotide dans une plante
AU2016270913A1 (en) 2015-06-03 2018-01-04 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants
CA2987992A1 (fr) 2015-06-04 2016-12-08 University Of Southern California Immunotherapie des cellules car ciblees par lym-1 et lym-2
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
EP4026563A1 (fr) 2015-06-18 2022-07-13 Yeda Research and Development Co. Ltd Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
WO2016203476A1 (fr) 2015-06-18 2016-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
CN108289851B (zh) 2015-06-19 2021-06-01 Opko生物科学有限公司 长效凝固因子及其产生方法
WO2016207402A1 (fr) 2015-06-26 2016-12-29 Institute For Research In Biomedicine Protéines comprenant un fragment lair-1 muté et leurs utilisations
KR20210089270A (ko) 2015-07-16 2021-07-15 바이오카인 테라퓨틱스 리미티드 암 치료용 조성물 및 방법
CA2991690A1 (fr) 2015-07-16 2017-01-19 Yeda Research And Development Co. Ltd. Lymphocytes t a memoire centrale anti-tiers genetiquement modifies et leur utilisation en immunotherapie
EP3907231A1 (fr) 2015-07-19 2021-11-10 Yeda Research and Development Co., Ltd. Inhibiteurs séléctifs de na,k-atpase contenant des isoformes alpha2 et leur utilisation pour réduire la pression intraoculaire
WO2017013661A1 (fr) 2015-07-22 2017-01-26 Phytopharma International Ltd. Compositions consommables par les abeilles, procédés d'utilisation de ces compositions pour la production de miel, et miel produit par ces procédés
ES2865024T3 (es) 2015-07-29 2021-10-14 Hadasit Med Res Service Producción a gran escala de células de epitelio pigmentario retiniano
ES2965461T3 (es) 2015-08-03 2024-04-15 Biokine Therapeutics Ltd Inhibidor de CXCR4 para el tratamiento del cáncer
WO2017021961A1 (fr) 2015-08-04 2017-02-09 Yeda Research And Development Co. Ltd. Procédés de criblage pour riborégulateurs et atténuateurs
AU2016303631B2 (en) 2015-08-05 2022-07-28 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
PL3331994T3 (pl) 2015-08-05 2023-01-30 Cell Cure Neurosciences Ltd. Wytwarzanie komórek nabłonka barwnikowego siatkówki
US10639350B2 (en) 2015-08-10 2020-05-05 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Methods and pharmaceutical compositions for improving wound healing using CD24
US20180237790A1 (en) 2015-08-13 2018-08-23 Forrest Innovation Ltd. Formulations and compositions for delivery of nucleic acids to plant cells
WO2017033188A1 (fr) 2015-08-24 2017-03-02 Yeda Research And Development Co. Ltd. Huile et biocarburant d'origine algale et leurs procédés de production
US10765706B2 (en) 2015-09-03 2020-09-08 University Of South Florida Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
WO2017042814A1 (fr) 2015-09-10 2017-03-16 Yeda Research And Development Co. Ltd. Utilisation de cellules dendritiques immatures positives pour la perforine dans le traitement de maladie
WO2017059878A1 (fr) 2015-10-07 2017-04-13 Humabs Biomed Sa Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
EP3365376A1 (fr) 2015-10-25 2018-08-29 Yeda Research and Development Co., Ltd. Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
JP6987769B2 (ja) 2015-10-26 2022-01-05 セル キュア ニューロサイエンシズ リミテッド 網膜色素上皮細胞の調製法
CN109310648B (zh) 2015-10-27 2022-06-03 杰伊制药公司 用于治疗癌症的包含大麻二酚和第二治疗剂的组合物
IL242380A0 (en) 2015-10-29 2016-02-01 Yeda Res & Dev A method for inducing the division of cardiomyocytes and treating heart diseases
EP3370791A1 (fr) 2015-11-03 2018-09-12 Ariel-University Research and Development Company Ltd. Compositions destinées à la régénération et à la réparation de tissu nerveux
EP3374524A4 (fr) 2015-11-11 2019-06-26 Ramot at Tel-Aviv University Ltd. Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
IL293289B2 (en) 2015-11-30 2024-04-01 Kadimastem Ltd Methods for differentiation and purification of pancreatic endocrine cells
EP3176183A1 (fr) 2015-12-02 2017-06-07 Yeda Research and Development Co. Ltd Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
EP3389678B1 (fr) 2015-12-16 2022-06-15 Ramot at Tel-Aviv University Ltd. Particules comprenant un omentum décellularisé
EP3397344A4 (fr) 2015-12-28 2019-08-28 B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University Composition et méthode pour le traitement de la sclérose latérale amyotrophique
US10828318B2 (en) 2016-01-06 2020-11-10 Yeda Research And Development Co. Ltd. Compositions and methods for treating malignant, autoimmune and inflammatory diseases
US20190178888A1 (en) 2016-01-11 2019-06-13 Technion Research & Development Foundation Limited Methods of determining prognosis of sepsis and treating same
EP3402513A4 (fr) 2016-01-13 2019-10-23 Medlmmune, LLC Méthode de traitement de la grippe a
WO2017125931A1 (fr) 2016-01-21 2017-07-27 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Plantes parthénocarpiques et procédés de production de celles-ci
IL243839B (en) 2016-01-28 2018-01-31 Sp Nano Ltd Conductive wires
IL243838A (en) 2016-01-28 2017-07-31 Sp Nano Ltd The composition containing sp1 protein and carbon nanoparticles and its uses
WO2017130205A1 (fr) 2016-01-31 2017-08-03 Hadasit Medical Research Services And Development Ltd. Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
EP3411390A1 (fr) 2016-02-04 2018-12-12 Yeda Research and Development Co. Ltd Peptides et leur utilisation dans le traitement de maladies, troubles ou affections associés à un p53 mutant
WO2017138008A2 (fr) 2016-02-14 2017-08-17 Yeda Research And Development Co. Ltd. Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
ES2771223T3 (es) 2016-02-14 2020-07-06 Yeda Res & Dev Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
CA3014889A1 (fr) 2016-02-16 2017-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Analogues de phenylalanine non proteiques pour inhiber la croissance vegetale et de cyanobacteries
EP3420075A4 (fr) 2016-02-23 2019-10-16 Chaya Brodie Production de cellules souches cancéreuses et leur utilisation
US10906987B2 (en) 2016-03-01 2021-02-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Antibodies specific to human poliovirus receptor (PVR)
IL294121B2 (en) 2016-03-03 2023-09-01 Memed Diagnostics Ltd An RNA test to diagnose the type of infection
US20190216891A1 (en) 2016-03-06 2019-07-18 Yeda Research And Development Co., Ltd. Method for modulating myelination
IL244649A0 (en) 2016-03-17 2016-06-30 Yeda Res & Dev Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
US10421785B2 (en) 2016-04-11 2019-09-24 Bar-Ilan University Delta receptor agonist peptides and use thereof
EP3448998B1 (fr) 2016-04-27 2020-06-03 Gen-Probe Incorporated Réactif de lyse de cellules sanguines
CN109475581A (zh) 2016-05-22 2019-03-15 耶达研究及发展有限公司 为了移植及诱导耐受性而使用肺细胞的方法
IL245861A0 (en) 2016-05-25 2016-09-04 Yeda Res & Dev Use of substances to treat drug-resistant tumors
US20190100732A1 (en) 2016-06-02 2019-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
EP3464322B1 (fr) 2016-06-05 2023-04-05 Tel HaShomer Medical Research Infrastructure and Services Ltd. Nouvelles molécules destinées au traitement de l'inflammation
WO2017212494A1 (fr) 2016-06-09 2017-12-14 Opko Biologics Ltd. Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
CN109689894A (zh) 2016-06-19 2019-04-26 耶路撒冷希伯来大学伊萨姆研发有限公司 在人单倍体细胞中筛选化学疗法抗性
AU2017289879B2 (en) 2016-06-27 2023-04-20 Yeda Research And Development Co. Ltd. Veto cells generated from memory T cells
EP4184167A1 (fr) 2016-07-10 2023-05-24 MeMed Diagnostics Ltd. Diagnostic précoce d'infections
CN109661578B (zh) 2016-07-10 2022-05-10 米密德诊断学有限公司 用于区分细菌和病毒感染的蛋白质特征
EP3481967A4 (fr) 2016-07-11 2020-04-22 Bonus Therapeutics Ltd. Compositions cellulaires pour la régénération tissulaire
IL246722A0 (en) 2016-07-11 2016-09-29 Yeda Res & Dev Combined treatment to increase endogenous synthesis of nitric oxide
CN109714962A (zh) 2016-07-11 2019-05-03 耶路撒冷希伯来大学的益生研究开发有限公司 用于在体外培养细胞的系统和方法
KR20240006077A (ko) 2016-07-11 2024-01-12 옵코 바이오로직스 리미티드 지속성 응고 인자 vii 및 그 제조 방법
WO2018010789A1 (fr) 2016-07-13 2018-01-18 Humabs Biomed Sa Nouveaux anticorps se liant spécifiquement aux épitopes du virus zika et leurs utilisations
WO2018015881A1 (fr) 2016-07-18 2018-01-25 Ramot At Tel-Aviv University Ltd. Plate-forme modulaire pour thérapie ciblée
US20190203270A1 (en) 2016-07-24 2019-07-04 Yeda Research And Development Co., Ltd. Methods and kits for analyzing dna binding moieties attached to dna
WO2018029682A1 (fr) 2016-08-08 2018-02-15 Ramot At Tel-Aviv University Ltd. Systèmes bactériens servant à analyser des polypeptides ubiquitinylés
US10633706B2 (en) 2016-08-10 2020-04-28 Ramot At Tel-Aviv University Ltd. Analysis of methylation status and copy number
US20190180846A1 (en) 2016-08-10 2019-06-13 Memed Diagnostics Ltd. System and method for analysis of biological data
SG11201901272WA (en) 2016-08-14 2019-03-28 Univ Ramot Mesenchymal cell-derived exosomes to treat neurological disorders
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
WO2018037416A1 (fr) 2016-08-25 2018-03-01 Yeda Research And Development Co. Ltd. Procédés et compositions pour le traitement de maladies auto-immunes
WO2018047154A1 (fr) 2016-09-07 2018-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anticorps anti-nkp46 et leur utilisation thérapeutique
WO2018051347A1 (fr) 2016-09-14 2018-03-22 Yeda Research And Development Co. Ltd. Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
EP3519833A4 (fr) 2016-09-29 2020-06-03 MeMed Diagnostics Ltd. Méthodes de pronostic et de traitement
IL248468A0 (en) 2016-10-13 2017-01-31 Technion Res & Dev Foundation Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
IL248385A0 (en) 2016-10-18 2017-02-01 Yeda Res & Dev Treatment of circadian rhythm disorder
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
US20190359956A1 (en) 2016-11-10 2019-11-28 Yeda Research And Development Co. Ltd. Phosphotriesterases for treating or preventing organophosphate exposure associated damage
US11542508B2 (en) 2016-11-28 2023-01-03 Yeda Research And Development Co. Ltd. Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
WO2018100574A1 (fr) 2016-11-30 2018-06-07 Yeda Research And Development Co. Ltd. Méthodes de traitement de maladies et de la toxicité hépathique
MX2018016003A (es) 2016-12-01 2019-05-16 Univ Ramot Tratamiento combinado para lesiones neurológicas.
US11555178B2 (en) 2017-01-18 2023-01-17 Yeda Research And Development Co. Ltd. Genetically modified veto cells and use of same in immunotherapy
IL250479A0 (en) 2017-02-06 2017-03-30 Sorek Rotem Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
IL250916A0 (en) 2017-03-02 2017-06-29 Geiger Benjamin Methods for growing t cells in culture and their use
WO2018167778A1 (fr) 2017-03-12 2018-09-20 Yeda Research And Development Co. Ltd. Procédés de diagnostic et de pronostic du cancer
WO2018167780A1 (fr) 2017-03-12 2018-09-20 Yeda Research And Development Co. Ltd. Méthodes de diagnostic et de traitement du cancer
EP3595687A1 (fr) 2017-03-16 2020-01-22 Lineage Cell Therapeutics, Inc. Procédés de mesure d'effets thérapeutiques de traitements de maladies rétiniennes
ES2963461T3 (es) 2017-04-05 2024-03-27 Yeda Res & Dev Sistema de cultivo ex vivo y métodos de utilización del mismo
EA201992434A1 (ru) 2017-04-19 2020-03-30 Инститьют Фор Рисерч Ин Байомедисин Новые противомалярийные вакцины и антитела, связывающиеся со спорозоитами плазмодия
IL252151A0 (en) 2017-05-07 2017-07-31 Fainzilber Michael Treatment of stress disorders
JP7445429B2 (ja) 2017-05-10 2024-03-07 アリエル サイエンティフィック イノベーションズ リミテッド 抗体の精製法
US11714089B2 (en) 2017-05-21 2023-08-01 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Combination of markers for diagnosing cancer
WO2018216011A1 (fr) 2017-05-23 2018-11-29 Technion Research & Development Foundation Limited Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
US20200109408A1 (en) 2017-05-31 2020-04-09 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
GB201708662D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing shelf-life of banana
GB201708665D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing extractability of solids from coffee beans
WO2018229764A1 (fr) 2017-06-13 2018-12-20 Yeda Research And Development Co. Ltd. Traitement de la sclérose en plaques avancée ou progressive
EP3652342A1 (fr) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Détection d'adn spécifique d'un tissu
EP3652343A1 (fr) 2017-07-13 2020-05-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
EP3652344A1 (fr) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
IL253642A0 (en) 2017-07-24 2017-09-28 Seger Rony Combined treatment for cancer
IL253984A0 (en) 2017-08-14 2017-09-28 Yeda Res & Dev Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
WO2019038771A1 (fr) 2017-08-23 2019-02-28 Technion Research & Development Foundation Limited Compositions et procédés d'amélioration de la tolérance à l'alcool dans la levure
WO2019042555A1 (fr) 2017-08-31 2019-03-07 Humabs Biomed Sa Anticorps multispécifiques se liant spécifiquement aux épitopes du virus zika et leurs utilisations
AU2018336126A1 (en) 2017-09-19 2020-04-30 Tropic Biosciences UK Limited Modifying the specificity of non-coding RNA molecules for silencing gene expression in eukaryotic cells
CN111587123A (zh) 2017-11-09 2020-08-25 品通治疗有限公司 用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物
IL255664A0 (en) 2017-11-14 2017-12-31 Shachar Idit Hematopoietic stem cells with enhanced properties
IL274979B1 (en) 2017-11-29 2024-03-01 Univ Ramot Methods for the prevention and treatment of neurogenic seizures
EP3716756A4 (fr) 2017-11-29 2021-09-15 Weedout Ltd. Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
WO2019106680A1 (fr) 2017-12-03 2019-06-06 Yeda Research And Development Co. Ltd. Traitement d'une maladie cardiaque ischémique
WO2019116376A1 (fr) 2017-12-17 2019-06-20 Yeda Research And Development Co. Ltd. Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
WO2019130313A1 (fr) 2017-12-28 2019-07-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
IL257225A (en) 2018-01-29 2018-04-09 Yeda Res & Dev Treatment of sarcoma
IL257269A (en) 2018-01-31 2018-04-09 Olender Tsviya Signaling is directed to the endoplasmic reticulum
WO2019155459A1 (fr) 2018-02-08 2019-08-15 Yeda Research And Development Co. Ltd. Inhibiteurs du protéasome 20s
EP3749368A1 (fr) 2018-02-08 2020-12-16 Yeda Research and Development Co. Ltd Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
WO2019162945A1 (fr) 2018-02-23 2019-08-29 Carmel Haifa University Economic Corporation Ltd. Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
EP3759493A1 (fr) 2018-02-28 2021-01-06 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Méthodes de diagnostic et de traitement du cancer de la vessie
EP3765034A1 (fr) 2018-03-12 2021-01-20 Yeda Research and Development Co. Ltd Traitement d'une maladie cardiaque
WO2019183500A1 (fr) 2018-03-23 2019-09-26 Hung Chiung Yu Antigènes de coccidioides et leurs procédés d'utilisation
IL258467A (en) 2018-03-29 2018-07-04 Ilana Kolodkin Gal Methods of disrupting a biofilm and/or preventing formation of same
EP3774047A1 (fr) 2018-03-29 2021-02-17 Yeda Research and Development Co. Ltd Utilisation de gradients de champ électrique pour commander l'expression génique
CN112236131A (zh) 2018-03-29 2021-01-15 技术研究及发展基金有限公司 包含pten抑制剂的囊泡及其用途
GB201807192D0 (en) 2018-05-01 2018-06-13 Tropic Biosciences Uk Ltd Compositions and methods for reducing caffeine content in coffee beans
IL259392A (en) 2018-05-15 2018-08-01 Yeda Res & Dev Vaccination with cancer neo-antigens
WO2019220441A1 (fr) 2018-05-15 2019-11-21 Hadasit Medical Research Services And Development Ltd. Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
AU2019277908A1 (en) 2018-05-27 2021-01-07 Biolinerx Ltd. AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
CN112384063A (zh) 2018-06-07 2021-02-19 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 再生及转殖大麻的方法
WO2019234754A1 (fr) 2018-06-07 2019-12-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Constructions d'acide nucléique et procédés d'utilisation de celles-ci
WO2020003311A1 (fr) 2018-06-25 2020-01-02 Yeda Research And Development Co. Ltd. Systèmes et procédés permettant d'améliorer l'efficacité de l'édition génomique
AU2019297677A1 (en) 2018-07-04 2021-02-25 Ukko Inc. Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
US20210269860A1 (en) 2018-07-08 2021-09-02 Yeda Research And Development Co. Ltd. Person-specific assessment of probiotics responsiveness
CN112351989B (zh) 2018-07-11 2024-03-26 免疫制药有限公司 肽化合物及其治疗用途
US20210214417A1 (en) 2018-07-11 2021-07-15 Kahr Medical Ltd. SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
BR112021001586A2 (pt) 2018-07-31 2021-05-04 Collplant Ltd. evento transgênico do tabaco e métodos para detecção e uso dos mesmos
IL261156A (en) 2018-08-14 2020-02-27 Fass Deborah Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
WO2020041360A1 (fr) 2018-08-21 2020-02-27 Quidel Corporation Anticorps dbpa et leurs utilisations
EP3841201A1 (fr) 2018-08-24 2021-06-30 Yeda Research and Development Co. Ltd Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
US20210353611A1 (en) 2018-09-20 2021-11-18 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral sclerosis
US20210338767A1 (en) 2018-09-25 2021-11-04 Biolinerx Ltd. Methods of selecting treatment for cxcr4-associated cancer
IL262658A (en) 2018-10-28 2020-04-30 Memorial Sloan Kettering Cancer Center Prevention of age related clonal hematopoiesis and diseases associated therewith
IL263184A (en) 2018-11-21 2020-05-31 Yarden Yosef Method of treating cancer and compositions for same
EP4292659A3 (fr) 2018-12-19 2024-03-20 Humabs Biomed SA Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
EP3914698A1 (fr) 2019-01-23 2021-12-01 Yeda Research and Development Co. Ltd Milieux de culture pour cellules souches pluripotentes
IL264768A (en) 2019-02-10 2020-08-31 Sagi Irit ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
IL264854A (en) 2019-02-14 2020-08-31 Bahat Anat Spt5 inhibitors and methods of use thereof
WO2020170239A1 (fr) 2019-02-21 2020-08-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
WO2020170240A1 (fr) 2019-02-21 2020-08-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de réduction d'une néphrotoxicité induite par des médicaments
AU2020232441A1 (en) 2019-03-05 2021-09-23 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Genome-edited birds
GB201903520D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
GB201903519D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
GB201903521D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd No title
IL265486A (en) 2019-03-19 2020-09-30 Yeda Res & Dev Bistable type ii opsins and uses thereof
EP3947454A1 (fr) 2019-03-27 2022-02-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Protéines recombinantes ayant des propriétés d'activation de cd40
WO2020194317A1 (fr) 2019-03-28 2020-10-01 Yeda Research And Development Co. Ltd. Méthode de traitement de troubles liés aux lipides
US20220175807A1 (en) 2019-03-31 2022-06-09 Yeda Research And Development Co. Ltd. Anti-viral and anti-tumoral compounds
IL266433B (en) 2019-05-02 2020-11-30 Sagi Irit Compositions comprising the propeptide of lysyl oxidase and uses thereof
US20220220559A1 (en) 2019-05-13 2022-07-14 Yeda Research And Development Co. Ltd. Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
IL266728B (en) 2019-05-19 2020-11-30 Yeda Res & Dev Identification of recurrent mutant neopeptides
AU2020279080A1 (en) 2019-05-22 2022-01-20 Hadasit Medical Research Services And Development Ltd. Methods of culturing human pluripotent cells
GB2598520A (en) 2019-05-28 2022-03-02 Univ Shanghai Technology Composition and methods to treat ectodermal dysplasia 2, Clouston type
CA3141995A1 (fr) 2019-06-12 2020-12-17 Hadasit Medical Research Services And Development Ltd. Procedes de generation d'oligodendrocytes
EP3983540A1 (fr) 2019-06-16 2022-04-20 Yeda Research and Development Co. Ltd Méthode de stabilisation de l'arn intracellulaire
EP3990488A4 (fr) 2019-06-27 2023-09-13 Ramot at Tel-Aviv University Ltd. Anticorps semaphorine 3a et leurs utilisations
US20220251148A1 (en) 2019-07-04 2022-08-11 Ukko Inc. De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
CA3146248A1 (fr) 2019-07-11 2021-01-14 Kahr Medical Ltd. Heterodimeres et procedes d'utilisation correspondants
IL268111A (en) 2019-07-16 2021-01-31 Fainzilber Michael Methods of treating pain
WO2021009740A1 (fr) 2019-07-16 2021-01-21 Ramot At Tel-Aviv University Ltd. Compositions et procédés pour le traitement de la tuberculose
CA3147575A1 (fr) 2019-07-29 2021-02-04 Yeda Research And Development Co. Ltd. Procedes de traitement et de diagnostic du cancer du poumon
CA3148950A1 (fr) 2019-07-30 2021-02-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center Methodes de regulation de la synthese de cannabinoides chez la plante ou dans des cellules et plantes et cellules ainsi produites
WO2021028909A1 (fr) 2019-08-12 2021-02-18 Yeda Research And Development Co. Ltd. Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
US20240140988A1 (en) 2019-08-22 2024-05-02 Ariel Scientific Innovations Ltd. Scaled-up methods for purifying antibodies
WO2021038569A1 (fr) 2019-08-27 2021-03-04 Yeda Research And Development Co. Ltd. Traitement de la vaginose bactérienne
BR112022003698A2 (pt) 2019-08-29 2022-05-24 Vir Biotechnology Inc Método de tratamento de uma infecção pelo vírus da hepatite b e composição farmacêutica
WO2021048852A1 (fr) 2019-09-11 2021-03-18 Yeda Research And Development Co. Ltd. Méthodes de traitement du cancer du sein
IL269674B (en) 2019-09-25 2020-08-31 Roy Bar Ziv Assembling protein complexes on a chip
IL270306A (en) 2019-10-30 2021-05-31 Yeda Res & Dev Prevention and treatment of pre-myeloid and myeloid malignancies
WO2021084526A1 (fr) 2019-10-31 2021-05-06 Yeda Research And Development Co. Ltd. Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
CA3160506A1 (fr) 2019-11-11 2021-05-20 Ibi-Ag Innovative Bio Insecticides Ltd. Nanocorps de lutte contre les insectes et leurs utilisations
US20230022576A1 (en) 2019-11-19 2023-01-26 Protalix Ltd. Removal of constructs from transformed cells
IL270800A (en) 2019-11-20 2021-05-31 Yeda Res & Dev A method for treating Alzheimer's disease
JP2023502712A (ja) 2019-11-21 2023-01-25 インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） 抗ｐｄ－１／ｉｌ－１５免疫サイトカインによる新しいｐｄ－１標的免疫療法
CN112898414B (zh) 2019-12-04 2024-05-10 珠海泰诺麦博制药股份有限公司 抗人巨细胞病毒抗体及其用途
EP4077731A1 (fr) 2019-12-22 2022-10-26 Yeda Research and Development Co. Ltd Diagnostic de la démence frontotemporale
IL271656A (en) 2019-12-22 2021-06-30 Yeda Res & Dev System and methods for identifying cells that have undergone genome editing
US20230048361A1 (en) 2019-12-31 2023-02-16 Kahr Medical Ltd. Methods of culturing t cells and uses of same
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
WO2021137231A1 (fr) 2019-12-31 2021-07-08 Kahr Medical Ltd. Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
IL272074A (en) 2020-01-15 2021-07-29 Immunity Pharma Ltd Peptide compounds and their use in methods of treating diseases
IL272194A (en) 2020-01-22 2021-07-29 Yeda Res & Dev Multi-target antibodies for use in the treatment of diseases
WO2021152584A1 (fr) 2020-01-28 2021-08-05 Ariel Scientific Innovations Ltd. Procédés d'analyse de membranes cellulaires
WO2021152586A1 (fr) 2020-01-30 2021-08-05 Yeda Research And Development Co. Ltd. Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
WO2021152587A1 (fr) 2020-01-30 2021-08-05 Yeda Research And Development Co. Ltd. Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
IL272389A (en) 2020-01-30 2021-08-31 Yeda Res & Dev Kits containing antibodies to PD-L1 and their uses in therapy
IL272390A (en) 2020-01-30 2021-08-31 Yeda Res & Dev Cancer treatment methods
CA3170374A1 (fr) 2020-02-09 2021-08-12 Nlc Pharma Ltd Test de detection rapide du sras-cov-2
IL272586A (en) 2020-02-10 2021-08-31 Yeda Res & Dev A method for cell cluster analysis
WO2021173674A1 (fr) 2020-02-26 2021-09-02 A2 Biotherapeutics, Inc. Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
US11376320B2 (en) 2020-03-05 2022-07-05 Iowa State University Research Foundation, Inc. Immunogenic and vaccine compositions against SARS-CoV-2
EP4121441A1 (fr) 2020-03-16 2023-01-25 Yeda Research and Development Co. Ltd Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
US20230132790A1 (en) 2020-03-29 2023-05-04 Yeda Research And Development Co. Ltd. Variants of beta-glucocerebrosidase for use in treating gaucher disease
AU2021248783A1 (en) 2020-03-31 2022-12-01 Biomuse Ltd. Bacteria for the prevention and treatment of smoke-induced lung damage
WO2021205444A1 (fr) 2020-04-06 2021-10-14 Yeda Research And Development Co. Ltd. Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
EP4132479A1 (fr) 2020-04-07 2023-02-15 Ramot at Tel-Aviv University Ltd. Compositions contenant du cannabidiol et leurs utilisations
EP4135746A1 (fr) 2020-04-13 2023-02-22 Exoprother Medical Ltd. Vésicules dérivées de cellules comprenant une protéine p53 de type sauvage pour une thérapie antivirale
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
WO2021229577A1 (fr) 2020-05-12 2021-11-18 Collplant Ltd. Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
JP2023525140A (ja) 2020-05-13 2023-06-14 アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） Ｏｘ４０活性化特性を有する組換えタンパク質
IL274811B (en) 2020-05-20 2021-05-31 Yeda Res & Dev Spatial information is developed for the analysis of individual cells
US20230242621A1 (en) 2020-06-24 2023-08-03 Vir Biotechnology, Inc. Engineered hepatitis b virus neutralizing antibodies and uses thereof
US20230293530A1 (en) 2020-06-24 2023-09-21 Yeda Research And Development Co. Ltd. Agents for sensitizing solid tumors to treatment
IL276599A (en) 2020-08-09 2022-03-01 Yeda Res & Dev T cell receptor unique to mage-a1 and its uses
IL276627A (en) 2020-08-10 2022-03-01 Yeda Res & Dev Compositions for diagnosis and treatment of coronavirus infections
EP4199703A1 (fr) 2020-08-18 2023-06-28 International Rice Research Institute Procédés d'augmentation des taux de croisement de gramineae
IL277488A (en) 2020-09-21 2022-04-01 Yeda Res & Dev Weight regulation method
IL301503A (en) 2020-09-23 2023-05-01 Yeda res & development co ltd Methods and preparations for the treatment of the disease caused by the corona virus
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
JP2023545999A (ja) 2020-10-05 2023-11-01 プロタリクス リミテッド ダイサー（ｄｉｃｅｒ）様ノックアウト植物細胞
JP2023545740A (ja) 2020-10-07 2023-10-31 プロタリクス リミテッド 長期活性ＤＮａｓｅ
WO2022079719A1 (fr) 2020-10-15 2022-04-21 Yeda Research And Development Co. Ltd. Méthode de traitement des cancers myéloïdes
IL278401A (en) 2020-10-29 2022-05-01 Yeda Res & Dev Polynucleotides for editing RNA and a method for using them
WO2022097157A2 (fr) 2020-11-09 2022-05-12 1E Therapeutics, Ltd. Méthodes de traitement ou de prévention d'infections bactériennes faisant appel à une séquence catalytique
AU2021387979A1 (en) 2020-11-26 2023-03-30 Ukko Inc. Modified high molecular weight glutenin subunit and uses thereof
IL279559A (en) 2020-12-17 2022-07-01 Yeda Res & Dev Controlling the ubiquitination process of mlkl for disease treatment
KR20230126725A (ko) 2020-12-28 2023-08-30 1이 테라퓨틱스 엘티디. 침묵화를 위한 P21 mRNA 표적 부위
EP4267742A2 (fr) 2020-12-28 2023-11-01 1E Therapeutics, Ltd. Arnm de p21 ciblant des dnazymes
AU2022206415A1 (en) 2021-01-10 2023-08-17 Supermeat The Essence Of Meat Ltd. Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
WO2022153286A1 (fr) 2021-01-14 2022-07-21 Yeda Research And Development Co. Ltd. Procédés de production de vitamine d
IL280340B (en) 2021-01-21 2022-04-01 Yeda Res & Dev Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
TW202245838A (zh) 2021-01-26 2022-12-01 美商維爾生物科技股份有限公司 用於治療b型肝炎病毒感染的組成物及方法
JP2024506954A (ja) 2021-02-18 2024-02-15 イェダ リサーチ アンド デベロップメント カンパニー リミテッド ワクチン作製用の遺伝子改変細菌
CA3208982A1 (fr) 2021-02-18 2022-08-25 Ravid STRAUSSMAN Procede de generation de vaccins
WO2022189558A2 (fr) 2021-03-10 2022-09-15 Mabylon Ag Anticorps dirigés contre la tdp-43 et méthodes d'utilisation de ceux-ci
IL281561A (en) 2021-03-16 2022-10-01 Yeda Res & Dev Methods and devices for growing mouse embryos outside the uterus
WO2022208369A1 (fr) 2021-03-30 2022-10-06 Biomx Ltd. Bactériophage de pseudomonas et ses utilisations
IL282188A (en) 2021-04-08 2022-11-01 Yeda Res & Dev Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
JP2024520907A (ja) 2021-05-12 2024-05-27 バイオエムエックス・リミテッド ブドウ球菌バクテリオファージ及びその使用
IL283563A (en) 2021-05-30 2022-12-01 Yeda Res & Dev Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
IL309061A (en) 2021-06-06 2024-02-01 Yeda res & development co ltd Combined cancer treatment
EP4355857A1 (fr) 2021-06-13 2024-04-24 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Procédé de reprogrammation de cellules humaines
CR20240020A (es) 2021-06-16 2024-02-28 Seedx Tech Inc Métodos de clasificación de semillas de matthiola
NL2028466B1 (en) 2021-06-16 2022-12-21 Sakata Holland B V Methods of sorting matthiola seeds
AU2022303086A1 (en) 2021-07-02 2024-01-18 Tropic Biosciences UK Limited Delay or prevention of browning in banana fruit
IL310226A (en) 2021-07-18 2024-03-01 Gamida Cell Ltd NK cell populations for treatment
WO2023002492A1 (fr) 2021-07-22 2023-01-26 Yeda Research And Development Co. Ltd. Optimisation de codon d'acides nucléiques
CA3226947A1 (fr) 2021-08-03 2023-02-09 Muhammad YASSIN Complexe tcr modifie et ses procedes d'utilisation
EP4130028A1 (fr) 2021-08-03 2023-02-08 Rhazes Therapeutics Ltd Complexe tcr modifié et leurs procédés d'utilisation
IL310716A (en) 2021-08-10 2024-04-01 Gamida Cell Ltd Transgenic NK cells, their production and use
GB202112865D0 (en) 2021-09-09 2021-10-27 Tropic Biosciences Uk Ltd Resistance to black sigatoka disease in banana
GB202112866D0 (en) 2021-09-09 2021-10-27 Tropic Biosciences Uk Ltd Resistance to fusarium wilt in a banana
IL286430A (en) 2021-09-14 2023-04-01 Yeda Res & Dev Multispecific antibodies for use in the treatment of diseases
WO2023105526A1 (fr) 2021-12-08 2023-06-15 Yeda Research And Development Co. Ltd. Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
WO2023144779A1 (fr) 2022-01-28 2023-08-03 Pfizer Inc. Variants d'antigène de coronavirus
WO2023209708A1 (fr) 2022-04-25 2023-11-02 Yeda Research And Development Co. Ltd. Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
WO2023242155A1 (fr) 2022-06-14 2023-12-21 Janssen Vaccines & Prevention B.V. Compositions et procédés pour le diagnostic d'une infection par le vih

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341239B (fr) * 1967-09-06 1971-12-20 Pharmacia Ab
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
FR2298798A1 (fr) * 1975-01-27 1976-08-20 Kabk Ab Dispositif et procede pour dosages quantitatifs immuno-chimiques
FR2325934A1 (fr) * 1975-09-29 1977-04-22 Cordis Corp Methode de detection de la presence d'un antigene associe a l'hepatite
FR2373795A1 (fr) * 1976-12-10 1978-07-07 Erba Carlo Spa Dosage immunologique par enzyme fixee
FR2426262A1 (fr) * 1978-05-19 1979-12-14 Becton Dickinson Co Procede d'essai de substances biologiques en phase solide
FR2433749A1 (fr) * 1978-07-28 1980-03-14 Abbott Lab Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
EP0038150A1 (fr) * 1980-04-10 1981-10-21 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Procédé de sérodiagnostic pour la syphilis et autres maladies
FR2511155A1 (fr) * 1981-08-10 1983-02-11 Corning Glass Works Detection d'anticorps auto-bloquant

Also Published As

Publication number Publication date
FI53894B (fi) 1978-05-02
FI53894C (fi) 1978-08-10
AU468151B2 (en) 1973-08-09
NL154600B (nl) 1977-09-15
CA1040082B (fr) 1978-10-10
CA958314A (en) 1974-11-26
DK150170B (da) 1986-12-22
DE2206103A1 (de) 1972-08-24
GB1363565A (en) 1974-08-14
DK150170C (da) 1987-06-29
AU3855272A (en) 1973-08-09
ZA72548B (en) 1972-10-25
NL7101728A (fr) 1972-08-14
ES399608A1 (es) 1974-11-16
CH573115A5 (fr) 1976-02-27
JPS5247011B1 (fr) 1977-11-29
SE451098B (sv) 1987-08-31
BE779209A (nl) 1972-05-30
US3791932A (en) 1974-02-12
DE2206103B2 (de) 1975-10-16
BR7200729D0 (pt) 1973-10-25

Similar Documents

Publication Publication Date Title
FR2126760A5 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2941471A (fr)
AU2742671A (fr)
AU2894671A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU2684071A (fr)
AU2755871A (fr)
AU2706571A (fr)
AU2740271A (fr)
AU2669471A (fr)
AU3038671A (fr)
AU2907471A (fr)
AU2836771A (fr)
AU2854371A (fr)
AU2875571A (fr)
AU2880771A (fr)
AU2885171A (fr)
AU2927871A (fr)
AU2654071A (fr)
AU2940971A (fr)
AU2938071A (fr)
AU2724971A (fr)

Legal Events

Date Code Title Description
CL Concession to grant licences
CL Concession to grant licences